Engagement	O
of	O
the	O
Lewis	O
X	O
antigen	O
(	O
CD15	O
)	O
results	O
in	O
monocyte	O
activation	O
.	O

We	O
previously	O
reported	O
that	O
monocyte	O
adhesion	O
to	O
tumor	B-cell_line
necrosis	I-cell_line
factor-alpha	I-cell_line
(	I-cell_line
TNF-alpha	I-cell_line
)	I-cell_line
-treated	I-cell_line
endothelial	I-cell_line
cells	I-cell_line
increased	O
expression	O
of	O
tissue	O
factor	O
and	O
CD36	B-protein
on	O
monocytes	O
.	O

Using	O
immunological	O
cross-linking	O
to	O
mimic	O
receptor	O
engagement	O
by	O
natural	O
ligands	O
,	O
we	O
now	O
show	O
that	O
CD15	O
(	O
Lewis	O
X	O
)	O
,	O
a	O
monocyte	B-protein
counter-receptor	I-protein
for	O
endothelial	B-protein
selectins	I-protein
may	O
participate	O
in	O
this	O
response	O
.	O

We	O
used	O
cytokine	O
production	O
as	O
a	O
readout	O
for	O
monocyte	O
activation	O
and	O
found	O
that	O
CD15	O
cross-linking	O
induced	O
TNF-alpha	B-protein
release	O
from	O
peripheral	B-cell_type
blood	I-cell_type
monocytes	I-cell_type
and	O
cells	O
from	O
the	O
monocytic	B-cell_line
cell	I-cell_line
line	I-cell_line
MM6	I-cell_line
.	O

Quantitative	O
reverse	B-protein
transcriptase	I-protein
-polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
showed	O
an	O
increase	O
in	O
steady-state	O
TNF-alpha	B-RNA
mRNA	I-RNA
after	O
3	O
to	O
4	O
hours	O
of	O
cross-linking	O
.	O

CD15	O
cross-linking	O
also	O
concomitantly	O
increased	O
interleukin-1	B-RNA
beta	I-RNA
(	I-RNA
IL-1	I-RNA
beta	I-RNA
)	I-RNA
mRNA	I-RNA
,	O
while	O
no	O
apparent	O
change	O
was	O
observed	O
in	O
the	O
levels	O
of	O
beta-actin	B-RNA
mRNA	I-RNA
,	O
indicating	O
specificity	O
.	O

To	O
examine	O
transcriptional	O
regulation	O
of	O
cytokine	B-DNA
genes	I-DNA
by	O
CD15	O
engagement	O
,	O
a	O
CAT	O
plasmid	O
reporter	O
construct	O
containing	O
IL-1	B-DNA
beta	I-DNA
promoter/enhancer	I-DNA
sequences	I-DNA
was	O
introduced	O
into	O
MM6	B-cell_line
.	O

Subsequent	O
cross-linking	O
of	O
CD15	O
increased	O
CAT	B-protein
activity	O
.	O

CD15	O
engagement	O
by	O
monoclonal	B-protein
antibody	I-protein
also	O
attenuated	O
IL-1	B-protein
beta	I-protein
transcript	O
degradation	O
,	O
demonstrating	O
that	O
signaling	O
via	O
CD15	O
also	O
had	O
posttranscriptional	O
effects	O
.	O

Nuclear	O
extracts	O
of	O
anti-	O
CD15	B-cell_type
cross-linked	I-cell_type
cells	I-cell_type
demonstrated	O
enhanced	O
levels	O
of	O
the	O
transcriptional	B-protein
factor	I-protein
activator	I-protein
protein-1	I-protein
,	O
minimally	O
changed	O
nuclear	B-protein
factor-kappa	I-protein
B	I-protein
,	O
and	O
did	O
not	O
affect	O
SV40	B-protein
promoter	I-protein
specific	I-protein
protein-1	I-protein
.	O

We	O
conclude	O
that	O
engagement	O
of	O
CD15	O
on	O
monocytes	O
results	O
in	O
monocyte	O
activation	O
.	O

In	O
addition	O
to	O
its	O
well-recognized	O
adhesive	O
role	O
,	O
CD15	O
may	O
function	O
as	O
an	O
important	O
signaling	O
molecule	O
capable	O
of	O
initiating	O
proinflammatory	O
events	O
in	O
monocytes	B-cell_type
that	O
come	O
into	O
contact	O
with	O
activated	O
endothelium	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Engagement	NULL
of	NULL
the	NULL
Lewis	NULL
X	NULL
Antigen	NULL
(	NULL
CD15	NULL
)	NULL
Results	NULL
in	NULL
Monocyte	NULL
Activation	NULL
By	NULL
Siu	NULL
K.	NULL
Lo	NULL
,	NULL
Douglas	NULL
T.	NULL
Golenbock	NULL
,	NULL
Philip	NULL
M.	NULL
Sass	NULL
,	NULL
Azmat	NULL
Maskati	NULL
,	NULL
Hong	NULL
Xu	NULL
,	NULL
and	NULL
Roy	NULL
L.	NULL
Silverstein	NULL
We	NULL
previously	NULL
reported	NULL
that	NULL
monocyte	NULL
adhesion	NULL
to	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-a	NULL
)	NULL
-treated	NULL
endothelial	NULL
cells	NULL
increased	NULL
expression	NULL
of	NULL
tissue	NULL
factor	NULL
and	NULL
CD36	NULL
on	NULL
monocytes	NULL
.	NULL

Using	NULL
immunological	NULL
cross-linking	NULL
to	NULL
mimic	NULL
receptor	NULL
engagement	NULL
by	NULL
natural	NULL
ligands	NULL
,	NULL
we	NULL
now	NULL
show	NULL
that	NULL
CD15	NULL
(	NULL
Lewis	NULL
X	NULL
)	NULL
,	NULL
a	NULL
monocyte	NULL
counter-receptor	NULL
for	NULL
endothelial	NULL
selectins	NULL
may	NULL
participate	NULL
in	NULL
this	NULL
response	NULL
.	NULL

We	NULL
used	NULL
cytokine	NULL
production	NULL
as	NULL
a	NULL
readout	NULL
for	NULL
monocyte	NULL
activation	NULL
and	NULL
found	NULL
that	NULL
CD15	NULL
cross-linking	NULL
induced	NULL
TNF-a	NULL
release	NULL
from	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
and	NULL
cells	NULL
from	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
MM6	NULL
.	NULL

Quantitative	NULL
reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
showed	NULL
an	NULL
increase	NULL
in	NULL
steady-state	NULL
TNF-a	NULL
mRNA	NULL
after	NULL
3	NULL
to	NULL
4	NULL
hours	NULL
of	NULL
cross-linking	NULL
.	NULL

CD15	NULL
cross-linking	NULL
also	NULL
concomitantly	NULL
increased	NULL
interleukin-1B	NULL
(	NULL
IL-1B	NULL
)	NULL
mRNA	NULL
,	NULL
while	NULL
no	NULL
apparent	NULL
change	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
B-actin	NULL
mRNA	NULL
,	NULL
indicating	NULL
specificity	NULL
.	NULL

To	NULL
examine	NULL
transcriptional	NULL
regulation	NULL
of	NULL
cytokine	NULL
genes	NULL
by	NULL
CD15	NULL
engage	NULL
EVERAL	NULL
STUDIES	NULL
HAVE	NULL
suggested	NULL
a	NULL
role	NULL
for	NULL
monocyte	NULL
adhesion	NULL
molecules	NULL
in	NULL
amplifying	NULL
cellular	NULL
signaling	NULL
and	NULL
thus	NULL
enhancing	NULL
monocyte	NULL
activation	NULL
.	NULL

Engagement	NULL
of	NULL
CD11/CD18	NULL
integrins	NULL
,	NULL
for	NULL
example	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
enhance	NULL
endotoxin-induced	NULL
monocyte	NULL
activation	NULL
.	NULL
``	NULL

We	NULL
have	NULL
recently	NULL
reported	NULL
that	NULL
monocyte	NULL
adhesion	NULL
to	NULL
cytokine-activated	NULL
endothelial	NULL
cells	NULL
induced	NULL
tissue	NULL
factor	NULL
(	NULL
TF	NULL
)	NULL
and	NULL
CD36	NULL
expression	NULL
on	NULL
the	NULL
monocyte	NULL
surface	NULL
and	NULL
that	NULL
engagement	NULL
of	NULL
endothelial	NULL
cell	NULL
E-selectin	NULL
with	NULL
monocyte	NULL
counter-receptors	NULL
,	NULL
such	NULL
as	NULL
CD15	NULL
(	NULL
Lewis	NULL
X	NULL
)	NULL
,	NULL
was	NULL
necessary	NULL
for	NULL
the	NULL
response	NULL
.	NULL
``	NULL

''	NULL
Weyrich	NULL
et	NULL
al	NULL
``	NULL
have	NULL
shown	NULL
that	NULL
monocyte	NULL
adhesion	NULL
to	NULL
P-selectin	NULL
also	NULL
induced	NULL
cell	NULL
activation	NULL
as	NULL
manifested	NULL
by	NULL
increased	NULL
secretion	NULL
of	NULL
monocyte	NULL
chemotactic	NULL
protein-1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF-	NULL
@	NULL
)	NULL
,	NULL
although	NULL
concomitant	NULL
stimulation	NULL
with	NULL
platelet-activating	NULL
factor	NULL
was	NULL
required	NULL
.	NULL

Recognition	NULL
of	NULL
endothelial	NULL
selectins	NULL
by	NULL
leukocytes	NULL
requires	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
specific	NULL
fucosylated	NULL
carbohydrate	NULL
structures	NULL
.	NULL
``	NULL

''	NULL
These	NULL
include	NULL
Lewis	NULL
X	NULL
(	NULL
CD15	NULL
)	NULL
,	NULL
sialylated	NULL
Lewis	NULL
X	NULL
(	NULL
sCD15	NULL
)	NULL
,	NULL
and	NULL
dimeric	NULL
sialylated	NULL
Lewis	NULL
X	NULL
(	NULL
dsCD15	NULL
)	NULL
.	NULL
``	NULL

''	NULL
CD15	NULL
and	NULL
related	NULL
carbohydrates	NULL
are	NULL
found	NULL
on	NULL
numerous	NULL
cellular	NULL
proteins	NULL
involved	NULL
in	NULL
cellular	NULL
adhesive	NULL
events	NULL
and	NULL
have	NULL
a	NULL
broad	NULL
cellular	NULL
distribution	NULL
including	NULL
leuko-cytes	NULL
``	NULL
and	NULL
tumor	NULL
cells	NULL
.	NULL
``	NULL

Most	NULL
of	NULL
the	NULL
CD15-related	NULL
antigens	NULL
are	NULL
present	NULL
on	NULL
either	NULL
glycoproteins	NULL
or	NULL
glycolipids	NULL
.	NULL

On	NULL
neutrophils	NULL
,	NULL
CD15	NULL
is	NULL
associated	NULL
with	NULL
several	NULL
proteins	NULL
of	NULL
various	NULL
molecular	NULL
weights	NULL
in	NULL
the	NULL
range	NULL
of	NULL
105	NULL
and	NULL
165	NULL
kD	NULL
.	NULL
``	NULL

Although	NULL
immunopreciptation	NULL
studies	NULL
indicate	NULL
that	NULL
CD15	NULL
is	NULL
present	NULL
on	NULL
CD11/CD18	NULL
integrins	NULL
,	NULL
'*	NULL
``	NULL
``	NULL
leukocytes	NULL
from	NULL
patients	NULL
genetically	NULL
deficient	NULL
in	NULL
CD11/CD18	NULL
(	NULL
Leukocyte	NULL
Adhesion	NULL
Deficiency	NULL
)	NULL
also	NULL
bear	NULL
CD15	NULL
.	NULL
``	NULL

Using	NULL
microsequence	NULL
and	NULL
mass	NULL
spectrometry	NULL
,	NULL
Mahrenholz	NULL
et	NULL
al	NULL
``	NULL
``	NULL
recently	NULL
established	NULL
that	NULL
CD15	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
a	NULL
member	NULL
of	NULL
the	NULL
carci-noembryonic	NULL
antigen-related	NULL
family	NULL
of	NULL
cell	NULL
adhesion	NULL
mole-cules	NULL
.	NULL

The	NULL
exact	NULL
identity	NULL
of	NULL
the	NULL
proteins	NULL
and	NULL
lipid	NULL
moieties	NULL
bearing	NULL
the	NULL
CD15	NULL
antigen	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
leukocyte	NULL
adhesion	NULL
and	NULL
signaling	NULL
is	NULL
not	NULL
known	NULL
.	NULL
``	NULL

''	NULL
Recently	NULL
putative	NULL
glycoprotein	NULL
ligands	NULL
for	NULL
P-selectin	NULL
(	NULL
designated	NULL
PSGL-1	NULL
)	NULL
and	NULL
E-selectin	NULL
(	NULL
designated	NULL
ESL-1	NULL
)	NULL
have	NULL
been	NULL
identified	NULL
on	NULL
human	NULL
and	NULL
mouse	NULL
leukocytes	NULL
,	NULL
respectively	NULL
.	NULL
``	NULL

Immunological	NULL
and	NULL
cDNA	NULL
transfection	NULL
studies	NULL
strongly	NULL
suggest	NULL
that	NULL
these	NULL
may	NULL
be	NULL
the	NULL
major	NULL
leukocyte	NULL
counter-recep-	NULL
Blood	NULL
,	NULL
Vol	NULL
89	NULL
,	NULL
No	NULL
1	NULL
(	NULL
January	NULL
1	NULL
)	NULL
,	NULL
1997	NULL
;	NULL
pp	NULL
307-314	NULL
ment	NULL
,	NULL
a	NULL
CAT	NULL
plasmid	NULL
reporter	NULL
construct	NULL
containing	NULL
IL-1§	NULL
promoter/enhancer	NULL
sequences	NULL
was	NULL
introduced	NULL
into	NULL
MMG	NULL
.	NULL

Subsequent	NULL
cross-linking	NULL
of	NULL
CD15	NULL
increased	NULL
CAT	NULL
activity	NULL
.	NULL

CD15	NULL
engagement	NULL
by	NULL
monoclonal	NULL
antibody	NULL
also	NULL
attenuated	NULL
IL-18	NULL
transcript	NULL
degradation	NULL
,	NULL
demonstrating	NULL
that	NULL
signaling	NULL
via	NULL
CD15	NULL
also	NULL
had	NULL
posttranscriptional	NULL
effects	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
anti-CD15	NULL
cross-linked	NULL
cells	NULL
demonstrated	NULL
enhanced	NULL
levels	NULL
of	NULL
the	NULL
transcriptional	NULL
factor	NULL
activator	NULL
protein-1	NULL
,	NULL
minimally	NULL
changed	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
did	NULL
not	NULL
affect	NULL
SV40	NULL
promoter	NULL
specific	NULL
protein-1	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
engagement	NULL
of	NULL
CD15	NULL
on	NULL
monocytes	NULL
results	NULL
in	NULL
monocyte	NULL
activation	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
well-recognized	NULL
adhesive	NULL
role	NULL
,	NULL
CD15	NULL
may	NULL
function	NULL
as	NULL
an	NULL
important	NULL
signaling	NULL
molecule	NULL
capable	NULL
of	NULL
initiating	NULL
proinflammatory	NULL
events	NULL
in	NULL
monocytes	NULL
that	NULL
come	NULL
into	NULL
contact	NULL
with	NULL
activated	NULL
endothelium	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

tors	NULL
for	NULL
P-	NULL
and	NULL
E-selectin	NULL
,	NULL
and	NULL
that	NULL
recognition	NULL
requires	NULL
expression	NULL
of	NULL
the	NULL
glycoprotein	NULL
ligand	NULL
and	NULL
the	NULL
fucosylated	NULL
carbohydrate	NULL
(	NULL
generated	NULL
by	NULL
expression	NULL
of	NULL
a	NULL
specific	NULL
fucosyl	NULL
transferase	NULL
)	NULL
.	NULL
``	NULL

Several	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
CD15	NULL
containing	NULL
structures	NULL
may	NULL
mediate	NULL
cell	NULL
activation	NULL
in	NULL
neutrophils	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
Anti-CD15	NULL
antibodies	NULL
inhibited	NULL
the	NULL
oxidative	NULL
burst	NULL
in	NULL
neutrophils	NULL
induced	NULL
by	NULL
zymosan	NULL
particles	NULL
and	NULL
inhibited	NULL
phagocyto-sis	NULL
of	NULL
IgG-	NULL
and	NULL
C-opsonized	NULL
particles	NULL
and	NULL
bacteria	NULL
.	NULL

'*	NULL
Furthermore	NULL
,	NULL
antibodies	NULL
to	NULL
CD15	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
a	NULL
transient	NULL
increase	NULL
in	NULL
CD11/CD18	NULL
binding	NULL
activity	NULL
in	NULL
neutro-phils	NULL
.	NULL
``	NULL

In	NULL
a	NULL
recent	NULL
study	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
anti-CD15	NULL
antibodies	NULL
inhibited	NULL
neutrophil	NULL
recruitment	NULL
in	NULL
vivo	NULL
and	NULL
prevented	NULL
the	NULL
neutrophil-dependent	NULL
pulmonary	NULL
vascular	NULL
injury	NULL
.	NULL
``	NULL

''	NULL
In	NULL
contrast	NULL
to	NULL
these	NULL
reported	NULL
studies	NULL
of	NULL
the	NULL
function	NULL
of	NULL
CD15	NULL
expressed	NULL
by	NULL
neutrophils	NULL
,	NULL
the	NULL
role	NULL
of	NULL
CD15	NULL
has	NULL
not	NULL
been	NULL
elucidated	NULL
on	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

Monocyte	NULL
adhesion	NULL
to	NULL
cytokine-activated	NULL
endothelial	NULL
cells	NULL
is	NULL
presumed	NULL
to	NULL
be	NULL
an	NULL
important	NULL
early	NULL
event	NULL
in	NULL
the	NULL
development	NULL
of	NULL
proinflammatory	NULL
lesions	NULL
and	NULL
atherosclerosis	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
binding	NULL
of	NULL
monocytes	NULL
to	NULL
activated	NULL
endothelium	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Division	NULL
of	NULL
Hematology	NULL
and	NULL
Oncology	NULL
,	NULL
Cornell	NULL
University	NULL
Medical	NULL
College	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Section	NULL
of	NULL
Infectious	NULL
Diseases	NULL
,	NULL
Boston	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
.	NULL

Submitted	NULL
January	NULL
22	NULL
,	NULL
1996	NULL
;	NULL
accepted	NULL
August	NULL
13	NULL
,	NULL
1996	NULL
.	NULL

Supported	NULL
by	NULL
Grant-In-Aid	NULL
from	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
to	NULL
SK.L	NULL
.	NULL

,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
No	NULL
.	NULL

HL49883	NULL
to	NULL
SK.L	NULL
.	NULL

,	NULL
GM47127	NULL
to	NULL
D.T.G	NULL
.	NULL

,	NULL
AI33087	NULL
to	NULL
D.T.G	NULL
.	NULL

,	NULL
AR42588	NULL
to	NULL
RL.S	NULL
.	NULL

,	NULL
and	NULL
HL46403	NULL
to	NULL
RL.S	NULL
.	NULL

D.T.G	NULL
.	NULL

is	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
Junior	NULL
Faculty	NULL
Award	NULL
from	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
and	NULL
S.K.L	NULL
.	NULL

is	NULL
a	NULL
fellow	NULL
of	NULL
the	NULL
Dorothy	NULL
Rodbell	NULL
Cohen	NULL
Foundation	NULL
for	NULL
Sarcoma	NULL
Research	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Siu	NULL
K.	NULL
Lo	NULL
,	NULL
PhD	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
(	NULL
Hematology	NULL
&	NULL
Oncology	NULL
)	NULL
,	NULL
Cornell	NULL
University	NULL
Medical	NULL
College	NULL
,	NULL
1300	NULL
York	NULL
Ave	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10021	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/97/8901-0006	NULL
$	NULL
3.00/0	NULL
307	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

308	NULL
induced	NULL
a	NULL
phenotypic	NULL
change	NULL
in	NULL
the	NULL
adherent	NULL
monocytes	NULL
resulting	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
tissue	NULL
factor	NULL
procoagulant	NULL
and	NULL
CD36	NULL
(	NULL
a	NULL
receptor	NULL
for	NULL
thrombospon-din	NULL
and	NULL
oxidized	NULL
light	NULL
density	NULL
lipoprotein	NULL
)	NULL
.	NULL
``	NULL

''	NULL
Engagement	NULL
of	NULL
E-selectin	NULL
with	NULL
its	NULL
counter-receptor	NULL
(	NULL
s	NULL
)	NULL
was	NULL
a	NULL
critical	NULL
part	NULL
of	NULL
this	NULL
phenotypic	NULL
transformation	NULL
.	NULL

We	NULL
thus	NULL
hypothesize	NULL
that	NULL
engagement	NULL
of	NULL
CD15	NULL
may	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
mediate	NULL
monocyte	NULL
activation	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
have	NULL
used	NULL
an	NULL
immunological	NULL
cross-linking	NULL
approach	NULL
to	NULL
mimic	NULL
the	NULL
engagement	NULL
of	NULL
CD15	NULL
during	NULL
monocyte	NULL
attachment	NULL
to	NULL
activated	NULL
endothelium	NULL
.	NULL

We	NULL
found	NULL
that	NULL
cross-linking	NULL
of	NULL
CD15	NULL
resulted	NULL
in	NULL
the	NULL
rapid	NULL
activation	NULL
of	NULL
monocytes	NULL
as	NULL
evidenced	NULL
by	NULL
translocation	NULL
of	NULL
transcriptional	NULL
factors	NULL
such	NULL
as	NULL
activator	NULL
protein-l1	NULL
(	NULL
AP-1	NULL
)	NULL
,	NULL
increased	NULL
cytokine	NULL
generation	NULL
,	NULL
and	NULL
upregulation	NULL
of	NULL
interleu-kin-183	NULL
gene	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
engagement	NULL
of	NULL
CD15	NULL
by	NULL
its	NULL
natural	NULL
ligands	NULL
may	NULL
result	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
macrophage	NULL
responses	NULL
and	NULL
thus	NULL
contribute	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
inflammation	NULL
and	NULL
vascular	NULL
disorders	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
.	NULL

-	NULL
RPMI-1640	NULL
and	NULL
M199	NULL
were	NULL
obtained	NULL
from	NULL
BioWhit-aker	NULL
(	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Hanks	NULL
'	NULL
balanced	NULL
salt	NULL
solution	NULL
,	NULL
Dulbecco	NULL
's	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
trypsin-EDTA	NULL
,	NULL
L-glutamine	NULL
,	NULL
and	NULL
penicillin-streptomycin	NULL
were	NULL
purchased	NULL
from	NULL
GIBCO	NULL
(	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
GIBCO	NULL
containing	NULL
<	NULL
1	NULL
ng/mL	NULL
of	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
.	NULL

LPS	NULL
(	NULL
Escherichia	NULL
Coli	NULL
,	NULL
15	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

All	NULL
reagents	NULL
were	NULL
checked	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
endotoxin	NULL
by	NULL
a	NULL
sensitive	NULL
Limulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
BioWhittaker	NULL
)	NULL
,	NULL
and	NULL
found	NULL
to	NULL
have	NULL
<	NULL
20	NULL
pg/mL	NULL
.	NULL

Human	NULL
platelet-poor	NULL
plasma	NULL
was	NULL
prepared	NULL
from	NULL
healthy	NULL
donors	NULL
.	NULL

Phosphoinositol	NULL
specific	NULL
phospholipase	NULL
C	NULL
(	NULL
PI-PLC	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

All	NULL
other	NULL
chemicals	NULL
were	NULL
of	NULL
reagent	NULL
grade	NULL
.	NULL

Monocytic	NULL
cells	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
freshly	NULL
drawn	NULL
blood	NULL
by	NULL
Ficoll-Hypaque	NULL
gradient	NULL
centrifugation	NULL
.	NULL
``	NULL

Typically	NULL
,	NULL
cell	NULL
viability	NULL
exceeded	NULL
98	NULL
%	NULL
as	NULL
assessed	NULL
by	NULL
Trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
monocytes	NULL
were	NULL
depleted	NULL
from	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
leukocytes	NULL
by	NULL
adhesion	NULL
to	NULL
plastic	NULL
tissue	NULL
cultured	NULL
dishes	NULL
(	NULL
Falcon	NULL
,	NULL
Frankin	NULL
Lakes	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
60	NULL
minutes	NULL
at	NULL
37°C	NULL
.	NULL

This	NULL
process	NULL
was	NULL
repeated	NULL
three	NULL
times	NULL
,	NULL
and	NULL
nonadherent	NULL
lymphocytes	NULL
were	NULL
then	NULL
harvested	NULL
by	NULL
washing	NULL
with	NULL
RPMI	NULL
1640	NULL
medium	NULL
.	NULL

For	NULL
studies	NULL
requiring	NULL
large	NULL
numbers	NULL
of	NULL
cells	NULL
(	NULL
eg	NULL
,	NULL
mRNA	NULL
levels	NULL
,	NULL
mRNA	NULL
degradation	NULL
,	NULL
and	NULL
electromobility	NULL
gel	NULL
shift	NULL
studies	NULL
)	NULL
,	NULL
we	NULL
used	NULL
a	NULL
human	NULL
monocyte-like	NULL
cell	NULL
line	NULL
,	NULL
Mono	NULL
Mac	NULL
6	NULL
(	NULL
MM6	NULL
)	NULL
provided	NULL
by	NULL
Dr	NULL
HW.L	NULL
.	NULL

Ziegler-Heitbrock	NULL
(	NULL
Institut	NULL
fur	NULL
Im-munologie	NULL
,	NULL
Universitat	NULL
Munchen	NULL
)	NULL
.	NULL

Pilot	NULL
studies	NULL
were	NULL
performed	NULL
to	NULL
verify	NULL
that	NULL
these	NULL
cells	NULL
behaved	NULL
similarly	NULL
to	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
in	NULL
terms	NULL
of	NULL
cytokine	NULL
and	NULL
tissue	NULL
factor	NULL
production	NULL
in	NULL
response	NULL
to	NULL
CD15	NULL
cross-linking	NULL
.	NULL

These	NULL
cells	NULL
have	NULL
been	NULL
extensively	NULL
characterized	NULL
and	NULL
shown	NULL
to	NULL
exhibit	NULL
morphological	NULL
,	NULL
biochemical	NULL
,	NULL
and	NULL
physiological	NULL
features	NULL
of	NULL
mature	NULL
monocytes	NULL
,	NULL
``	NULL
including	NULL
the	NULL
expression	NULL
of	NULL
CD14	NULL
and	NULL
CD15	NULL
as	NULL
assessed	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Antibodies	NULL
.	NULL

Purified	NULL
murine	NULL
anti-CD15	NULL
IgM	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
MoAbs	NULL
)	NULL
80H5	NULL
and	NULL
UN-172	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
Fifth	NULL
Workshop	NULL
and	NULL
Conference	NULL
on	NULL
Human	NULL
Leukocyte	NULL
Differentiation	NULL
Antigens	NULL
``	NULL
and	NULL
PM81	NULL
from	NULL
Medarex	NULL
(	NULL
West	NULL
Lebanon	NULL
,	NULL
NH	NULL
)	NULL
.	NULL

Murine	NULL
IgM	NULL
VIM2	NULL
against	NULL
CD65	NULL
(	NULL
dimeric	NULL
sialyl-CD15	NULL
)	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr	NULL
W.	NULL
Knapp	NULL
(	NULL
Kaumberg	NULL
,	NULL
Austria	NULL
)	NULL
.	NULL

Hybridomas	NULL
of	NULL
additional	NULL
control	NULL
IgM	NULL
MoAb	NULL
1B2	NULL
(	NULL
against	NULL
Type	NULL
II	NULL
lactosamine	NULL
chains	NULL
)	NULL
and	NULL
CSLEX1	NULL
(	NULL
against	NULL
sialyl-CD15	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Ascities	NULL
of	NULL
these	NULL
MoAbs	NULL
were	NULL
prepared	NULL
in	NULL
mice	NULL
using	NULL
a	NULL
standard	NULL
protocol	NULL
and	NULL
IgM	NULL
LO	NULL
ET	NULL
AL	NULL
subsequently	NULL
purified	NULL
by	NULL
gel-filtration	NULL
chromatography	NULL
(	NULL
Windsor	NULL
Park	NULL
Lab	NULL
Inc	NULL
,	NULL
Teaneck	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

IgG	NULL
anti-monocyte	NULL
control	NULL
antibodies	NULL
,	NULL
Hee	NULL
7	NULL
(	NULL
CD31	NULL
)	NULL
,	NULL
B4	NULL
(	NULL
CD11/18	NULL
)	NULL
,	NULL
and	NULL
W6/32	NULL
(	NULL
HLA	NULL
Class	NULL
I	NULL
)	NULL
were	NULL
from	NULL
Dr	NULL
W.	NULL
Muller	NULL
(	NULL
Rockefeller	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
Dr	NULL
S.	NULL
Wright	NULL
(	NULL
Rockefeller	NULL
University	NULL
)	NULL
,	NULL
and	NULL
ATCC	NULL
,	NULL
respectively	NULL
.	NULL

Anti-CD15	NULL
(	NULL
PM81	NULL
)	NULL
and	NULL
anti-CD31	NULL
(	NULL
hee	NULL
7	NULL
)	NULL
antibodies	NULL
were	NULL
fluorescein	NULL
conjugated	NULL
by	NULL
incubating	NULL
500	NULL
gL	NULL
of	NULL
MoAb	NULL
(	NULL
1	NULL
mg/mL	NULL
at	NULL
pH	NULL
9.0	NULL
)	NULL
with	NULL
50	NULL
pL	NULL
.	NULL

fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
(	NULL
1	NULL
mg/mL	NULL
)	NULL
in	NULL
the	NULL
dark	NULL
for	NULL
8	NULL
hours	NULL
at	NULL
4°C	NULL
.	NULL

Unbound	NULL
FITC	NULL
was	NULL
removed	NULL
by	NULL
extensive	NULL
dialysis	NULL
.	NULL

Affinity	NULL
purified	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
'	NULL
2	NULL
goat	NULL
antimouse	NULL
IgM	NULL
or	NULL
IgG	NULL
were	NULL
obtained	NULL
from	NULL
Jackson	NULL
Immunoresearch	NULL
(	NULL
West	NULL
Grove	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

All	NULL
MoAbs	NULL
were	NULL
used	NULL
at	NULL
saturating	NULL
concentrations	NULL
(	NULL
~10	NULL
pg/mL	NULL
)	NULL
at	NULL
a	NULL
level	NULL
that	NULL
resulted	NULL
in	NULL
minimal	NULL
cell	NULL
aggregation	NULL
as	NULL
assessed	NULL
by	NULL
flow	NULL
cytometry	NULL
and	NULL
light	NULL
microscopy	NULL
.	NULL

Cross-linking	NULL
studies	NULL
.	NULL

-	NULL
Monocytic	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
suspended	NULL
in	NULL
culture	NULL
medium	NULL
containing	NULL
10	NULL
pg	NULL
of	NULL
anti-CD15	NULL
MoAb	NULL
per	NULL
mL	NULL
and	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
;	NULL
fragments	NULL
of	NULL
goat	NULL
antimouse	NULL
IgM	NULL
or	NULL
IgG	NULL
(	NULL
10	NULL
pg/mL	NULL
)	NULL
at	NULL
4°C	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

To	NULL
allow	NULL
cross-linking	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
then	NULL
warmed	NULL
to	NULL
37°C	NULL
before	NULL
performing	NULL
assays	NULL
described	NULL
below	NULL
.	NULL
``	NULL

To	NULL
assess	NULL
for	NULL
optimal	NULL
cross-linking	NULL
,	NULL
in	NULL
some	NULL
studies	NULL
FITC-conjugated	NULL
antibodies	NULL
were	NULL
used	NULL
and	NULL
cells	NULL
were	NULL
examined	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
microscopy	NULL
10	NULL
minutes	NULL
after	NULL
rewarming	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
;	NULL
secondary	NULL
antibody	NULL
,	NULL
anti-CD15	NULL
(	NULL
PM81	NULL
,	NULL
IgM	NULL
)	NULL
stained	NULL
monocytic	NULL
cells	NULL
(	NULL
MM6	NULL
)	NULL
in	NULL
a	NULL
rim	NULL
pattern	NULL
consistent	NULL
with	NULL
a	NULL
uniform	NULL
surface	NULL
distribution	NULL
of	NULL
antigen	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cross-linking	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
}	NULL
,	NULL
however	NULL
,	NULL
the	NULL
fluoresence	NULL
pattern	NULL
changed	NULL
with	NULL
clear	NULL
demonstration	NULL
of	NULL
antigen	NULL
patching	NULL
and	NULL
capping	NULL
of	NULL
antigen	NULL
of	NULL
a	NULL
majority	NULL
of	NULL
cells	NULL
(	NULL
~70	NULL
%	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
seen	NULL
with	NULL
multiple	NULL
control	NULL
IgM	NULL
and	NULL
IgG	NULL
antimouse	NULL
monocytic	NULL
antibodies	NULL
.	NULL

A	NULL
fluorescence	NULL
micrograph	NULL
of	NULL
CD31	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
as	NULL
a	NULL
representative	NULL
example	NULL
.	NULL

Enzymatic	NULL
removal	NULL
of	NULL
monocyte	NULL
surface	NULL
CD14	NULL
.	NULL

Mononuclear	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
cells/mL	NULL
)	NULL
were	NULL
suspended	NULL
for	NULL
60	NULL
minutes	NULL
at	NULL
37°C	NULL
in	NULL
HEPES-buffered	NULL
RPMI	NULL
1640	NULL
containing	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
(	NULL
2	NULL
mg/mL	NULL
)	NULL
and	NULL
PI-PLC	NULL
(	NULL
10	NULL
U/mL	NULL
,	NULL
equivalent	NULL
to	NULL
~15	NULL
ug/	NULL
mL	NULL
)	NULL
.	NULL

After	NULL
the	NULL
treatment	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
RPMI	NULL
and	NULL
then	NULL
cross-linked	NULL
with	NULL
CD15	NULL
MoAb	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Loss	NULL
of	NULL
CD14	NULL
surface	NULL
expression	NULL
was	NULL
monitored	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
(	NULL
FACS	NULL
)	NULL
,	NULL
and	NULL
was	NULL
consistently	NULL
>	NULL
=70	NULL
%	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cytokine	NULL
assays	NULL
.	NULL

An	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
(	NULL
Clontech	NULL
Lab	NULL
,	NULL
Inc	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
used	NULL
to	NULL
monitor	NULL
the	NULL
release	NULL
of	NULL
TNF-a	NULL
from	NULL
monocytes	NULL
after	NULL
cross-linking	NULL
CD15	NULL
.	NULL
``	NULL

Quantitative	NULL
competitive	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
was	NULL
used	NULL
to	NULL
measure	NULL
steady-state	NULL
levels	NULL
of	NULL
TNF-	NULL
and	NULL
IL-1	NULL
,	NULL
mRNA	NULL
.	NULL
``	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
MM6	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
with	NULL
RNAzo	NULL
!	NULL

(	NULL
Biotecx	NULL
Lab	NULL
,	NULL
Inc	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
)	NULL
,	NULL
reversed	NULL
transcribed	NULL
,	NULL
``	NULL
and	NULL
a	NULL
known	NULL
amount	NULL
of	NULL
cDNA	NULL
(	NULL
0.2	NULL
uL	NULL
)	NULL
amplified	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
defined	NULL
concentrations	NULL
of	NULL
a	NULL
synthetic	NULL
competitor	NULL
DNA	NULL
for	NULL
30	NULL
cycles	NULL
using	NULL
specific	NULL
primer	NULL
pairs	NULL
(	NULL
Clontech	NULL
)	NULL
.	NULL

Control	NULL
reactions	NULL
included	NULL
RNA	NULL
samples	NULL
in	NULL
which	NULL
the	NULL
reverse	NULL
transcription	NULL
reaction	NULL
mixture	NULL
was	NULL
omitted	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
,	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
,	NULL
and	NULL
photo-graphed	NULL
.	NULL

The	NULL
negatives	NULL
of	NULL
the	NULL
photographs	NULL
were	NULL
analyzed	NULL
by	NULL
laser	NULL
densitometry	NULL
,	NULL
and	NULL
the	NULL
absolute	NULL
absorbance	NULL
values	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
determined	NULL
.	NULL

The	NULL
ratios	NULL
of	NULL
the	NULL
absorbance	NULL
of	NULL
the	NULL
relevant	NULL
PCR	NULL
product	NULL
pairs	NULL
were	NULL
plotted	NULL
against	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
competitor	NULL
DNA	NULL
and	NULL
the	NULL
concentration	NULL
of	NULL
PCR	NULL
product	NULL
calculated	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

-	NULL
Nuclear	NULL
extracts	NULL
of	NULL
monocytic	NULL
cells	NULL
(	NULL
MM6	NULL
)	NULL
were	NULL
harvested	NULL
using	NULL
the	NULL
modified	NULL
protocol	NULL
of	NULL
Schricber	NULL
et	NULL
al	NULL
``	NULL
``	NULL
following	NULL
cell	NULL
stimulation	NULL
with	NULL
either	NULL
CD15	NULL
cross-linking	NULL
or	NULL
bacterial	NULL
LPS	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
for	NULL
timed	NULL
intervals	NULL
from	NULL
15	NULL
to	NULL
180	NULL
minutes	NULL
at	NULL
37°C	NULL
.	NULL

Protein	NULL
concentrations	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
were	NULL
determined	NULL
using	NULL
the	NULL
bicinchoninic	NULL
acid	NULL
method	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
until	NULL
use	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CD15	NULL
MEDIATES	NULL
MONOCYTE	NULL
ACTIVATION	NULL
CTL	NULL
CD15	NULL
CD15	NULL
2	NULL
Ab	NULL
CD31	NULL
2°Ab	NULL
Fig	NULL
1	NULL
.	NULL

-	NULL
Cross-linking	NULL
induced	NULL
patching	NULL
and	NULL
capping	NULL
of	NULL
CD15	NULL
.	NULL

MM6	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
suspended	NULL
in	NULL
culture	NULL
medium	NULL
containing	NULL
10	NULL
ug	NULL
FITC-conjugated	NULL
anti-CD15	NULL
or	NULL
anti-CD31	NULL
MoAb	NULL
per	NULL
mL	NULL
and	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
;	NULL
fragments	NULL
of	NULL
goat	NULL
anti-mouse	NULL
IgM	NULL
(	NULL
for	NULL
CD15	NULL
)	NULL
or	NULL
IgG	NULL
(	NULL
for	NULL
CD31	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
ug/ml	NULL
at	NULL
4°C	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
and	NULL
then	NULL
warmed	NULL
to	NULL
37°C	NULL
for	NULL
10	NULL
minutes	NULL
and	NULL
examined	NULL
by	NULL
fluorescent	NULL
microscopy	NULL
.	NULL

Shown	NULL
are	NULL
phase-fluoresecence	NULL
pairs	NULL
(	NULL
A	NULL
and	NULL
B	NULL
,	NULL
respectively	NULL
)	NULL
for	NULL
cells	NULL
incubated	NULL
with	NULL
anti-CD15	NULL
alone	NULL
(	NULL
second	NULL
row	NULL
}	NULL
,	NULL
anti-CD15	NULL
plus	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
;	NULL
secondary	NULL
antibody	NULL
(	NULL
third	NULL
row	NULL
)	NULL
,	NULL
and	NULL
anti-CD31	NULL
plus	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
;	NULL
secondary	NULL
antibody	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

The	NULL
top	NULL
row	NULL
shows	NULL
cells	NULL
incubated	NULL
with	NULL
the	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
;	NULL
secondary	NULL
antibody	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
primary	NULL
antibody	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

-	NULL
Double-stranded	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
immunoglobulin	NULL
«	NULL
light	NULL
chain	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
(	NULL
5'-AGTTGAGGGGACTTTCCCAGGC-3	NULL
'	NULL
)	NULL
,	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
(	NULL
5'-CGCTTGATGAGTCAGCCGGAA-3	NULL
'	NULL
)	NULL
,	NULL
and	NULL
the	NULL
SV40	NULL
promoter	NULL
specific	NULL
protein-1	NULL
(	NULL
SP-1	NULL
)	NULL
consensus	NULL
sequence	NULL
(	NULL
5-ATTCGATCGGGGCGGGGCGAGC-3	NULL
``	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Delude	NULL
et	NULL
al	NULL
.	NULL
``	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
were	NULL
preincu-bated	NULL
with	NULL
the	NULL
protein	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
minutes	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radioactive	NULL
probe	NULL
to	NULL
assess	NULL
the	NULL
specificity	NULL
of	NULL
protein/DNA	NULL
complexes	NULL
.	NULL

Competition	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
nuclear	NULL
factor	NULL
«	NULL
kB	NULL
(	NULL
NF-kB	NULL
)	NULL
oligonucleotide	NULL
was	NULL
seen	NULL
with	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
,	NULL
but	NULL
not	NULL
with	NULL
excesses	NULL
of	NULL
the	NULL
AP-1	NULL
or	NULL
SP-1	NULL
oligonucleotides	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
thus	NULL
demonstrating	NULL
that	NULL
only	NULL
NF-kB	NULL
was	NULL
actually	NULL
present	NULL
in	NULL
the	NULL
nuclear	NULL
fraction	NULL
obtained	NULL
from	NULL
unstimulated	NULL
MM6	NULL
.	NULL

IL-1B	NULL
promotor	NULL
regulation	NULL
.	NULL

An	NULL
IL-18	NULL
promoter/enhancer	NULL
con	NULL
309	NULL
struct	NULL
consisting	NULL
of	NULL
-3757	NULL
bp	NULL
to	NULL
+15	NULL
bp	NULL
of	NULL
the	NULL
human	NULL
IL-1	NULL
,	NULL
gene	NULL
coupled	NULL
to	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
and	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene*	NULL
``	NULL
was	NULL
transfected	NULL
into	NULL
MMG	NULL
using	NULL
a	NULL
modified	NULL
DEAE-Dextran	NULL
method	NULL
.	NULL

After	NULL
48	NULL
hours	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
LPS	NULL
(	NULL
1	NULL
pg/mL	NULL
)	NULL
or	NULL
cross-linked	NULL
with	NULL
anti-CD15	NULL
for	NULL
16	NULL
hours	NULL
at	NULL
37°C	NULL
.	NULL

Unstimulated	NULL
cells	NULL
served	NULL
as	NULL
negative	NULL
controls	NULL
.	NULL

Following	NULL
stimulation	NULL
,	NULL
transfected	NULL
cells	NULL
were	NULL
then	NULL
harvested	NULL
and	NULL
disrupted	NULL
by	NULL
three	NULL
freeze-thaw	NULL
cycles	NULL
.	NULL

Supernatants	NULL
were	NULL
mixed	NULL
with	NULL
``	NULL
``	NULL
C	NULL
-chloramphenicol	NULL
(	NULL
DuPont	NULL
NEN	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
acetyl-CoA	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
6	NULL
hours	NULL
.	NULL

Acetylated	NULL
``	NULL
*C-chloramphenicol	NULL
species	NULL
were	NULL
separated	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
(	NULL
TLC	NULL
)	NULL
in	NULL
chloroform	NULL
:	NULL
metha-nol	NULL
(	NULL
vol/vol	NULL
,	NULL
95:5	NULL
)	NULL
.	NULL

The	NULL
dried	NULL
TLC	NULL
sheet	NULL
was	NULL
exposed	NULL
to	NULL
KODAK	NULL
X-OMAT	NULL
AR	NULL
film	NULL
(	NULL
VWR	NULL
Scientific	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
quantified	NULL
by	NULL
PhosphoImager	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
normalized	NULL
by	NULL
co-transfection	NULL
with	NULL
a	NULL
-galactosidase	NULL
expression	NULL
plasmid	NULL
.	NULL

IL-1B	NULL
mRNA	NULL
stability	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
CD15	NULL
cross-linking	NULL
affected	NULL
IL-18	NULL
mRNA	NULL
degradation	NULL
,	NULL
we	NULL
examined	NULL
mRNA	NULL
stability	NULL
in	NULL
monocytic	NULL
cells	NULL
(	NULL
MM6	NULL
)	NULL
treated	NULL
with	NULL
actinomycin	NULL
D	NULL
(	NULL
5	NULL
ug/	NULL
mL	NULL
)	NULL
,	NULL
which	NULL
blocks	NULL
the	NULL
initiation	NULL
of	NULL
mRNA	NULL
transcription	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
harvested	NULL
from	NULL
actinomycin	NULL
D-treated	NULL
MM6	NULL
at	NULL
different	NULL
times	NULL
(	NULL
0	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
hours	NULL
)	NULL
following	NULL
cell	NULL
stimulation	NULL
.	NULL

Quantitative	NULL
RT-PCR	NULL
was	NULL
then	NULL
performed	NULL
on	NULL
this	NULL
RNA	NULL
.	NULL

Statistical	NULL
analysis	NULL
.	NULL

-	NULL
All	NULL
values	NULL
were	NULL
expressed	NULL
as	NULL
means	NULL
+	NULL
standard	NULL
error	NULL
(	NULL
SE	NULL
)	NULL
.	NULL

Student	NULL
's	NULL
t-test	NULL
was	NULL
used	NULL
to	NULL
compare	NULL
means	NULL
for	NULL
statistical	NULL
significance	NULL
at	NULL
P	NULL
<	NULL
.05	NULL
.	NULL

RESULTS	NULL
Immunologic	NULL
Cross-Linking	NULL
CD15	NULL
on	NULL
Monocytes	NULL
Induced	NULL
TNF-a	NULL
Release	NULL
Cross-linking	NULL
CD15	NULL
on	NULL
human	NULL
mononuclear	NULL
leukocytes	NULL
with	NULL
any	NULL
of	NULL
three	NULL
MoAbs	NULL
(	NULL
ie	NULL
,	NULL
PM81	NULL
,	NULL
80H5	NULL
,	NULL
UN-172	NULL
)	NULL
induced	NULL
significant	NULL
TNF-	NULL
«	NULL
release	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

Time	NULL
course	NULL
studies	NULL
showed	NULL
that	NULL
TNF-	NULL
«	NULL
release	NULL
was	NULL
detected	NULL
by	NULL
2	NULL
to	NULL
3	NULL
hours	NULL
and	NULL
reached	NULL
a	NULL
peak	NULL
at	NULL
6	NULL
hours	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

At	NULL
6	NULL
hours	NULL
,	NULL
5	NULL
to	NULL
10	NULL
ng	NULL
of	NULL
TNF-a	NULL
was	NULL
present	NULL
per	NULL
mL	NULL
of	NULL
conditioned	NULL
media	NULL
harvested	NULL
from	NULL
anti-CD15	NULL
cross-linked	NULL
monocytes	NULL
,	NULL
compared	NULL
with	NULL
<	NULL
0.5	NULL
ng/mL	NULL
from	NULL
the	NULL
untreated	NULL
cells	NULL
,	NULL
thus	NULL
representing	NULL
>	NULL
10-fold	NULL
increase	NULL
from	NULL
the	NULL
basal	NULL
levels	NULL
.	NULL

Cross-linking	NULL
other	NULL
cell	NULL
surface	NULL
antigens	NULL
expressed	NULL
abundantly	NULL
on	NULL
monocytes	NULL
,	NULL
including	NULL
the	NULL
glycoproteins	NULL
CD31	NULL
,	NULL
CD11/CD18	NULL
,	NULL
and	NULL
HLA	NULL
with	NULL
IgG	NULL
MoAbs	NULL
did	NULL
not	NULL
induce	NULL
TNF-	NULL
@	NULL
release	NULL
.	NULL

Furthermore	NULL
,	NULL
cross-linking	NULL
structurally	NULL
related	NULL
carbohydrate	NULL
antigens	NULL
with	NULL
specific	NULL
IgM	NULL
MoAbs	NULL
,	NULL
including	NULL
nonsialylated	NULL
lactosamine	NULL
,	NULL
sialyl-CD15	NULL
,	NULL
and	NULL
dimeric	NULL
sialyl-CD15	NULL
also	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
,	NULL
demonstrating	NULL
specificity	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
established	NULL
that	NULL
lymphocytes	NULL
do	NULL
not	NULL
express	NULL
CD15®	NULL
and	NULL
treatment	NULL
of	NULL
mononuclear	NULL
fractions	NULL
that	NULL
had	NULL
been	NULL
depleted	NULL
of	NULL
monocytes	NULL
(	NULL
ie	NULL
,	NULL
>	NULL
95	NULL
%	NULL
CD2+*	NULL
lymphocytes	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
)	NULL
by	NULL
the	NULL
same	NULL
three	NULL
anti-CD15	NULL
antibodies	NULL
did	NULL
not	NULL
induce	NULL
detectable	NULL
TNF-a	NULL
release	NULL
(	NULL
<	NULL
0.1	NULL
ng/mL	NULL
,	NULL
n	NULL
=	NULL
3	NULL
experiments	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
monocytes	NULL
were	NULL
the	NULL
likely	NULL
source	NULL
of	NULL
the	NULL
TNF-a	NULL
released	NULL
from	NULL
the	NULL
mononuclear	NULL
cell	NULL
preparations	NULL
.	NULL

Bacterial	NULL
LPS	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
TNF-	NULL
«	NULL
release	NULL
from	NULL
monocytes	NULL
and	NULL
commonly	NULL
contaminates	NULL
many	NULL
reagents	NULL
.	NULL

LPS	NULL
concentrations	NULL
in	NULL
all	NULL
MoAb	NULL
preparations	NULL
were	NULL
<	NULL
0.06	NULL
ng/mL	NULL
as	NULL
determined	NULL
by	NULL
a	NULL
limulus	NULL
lysate	NULL
assay	NULL
.	NULL

We	NULL
also	NULL
performed	NULL
a	NULL
series	NULL
of	NULL
studies	NULL
showing	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
cross-linking	NULL
CD15	NULL
was	NULL
likely	NULL
not	NULL
the	NULL
result	NULL
of	NULL
undetectable	NULL
LPS	NULL
contamination	NULL
.	NULL

Neither	NULL
primary	NULL
nor	NULL
secondary	NULL
antibody	NULL
alone	NULL
was	NULL
sufficient	NULL
to	NULL
induce	NULL
TNF-a	NULL
release	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

LPS	NULL
is	NULL
heat	NULL
stable	NULL
,	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

310	NULL
6	NULL
Lymphocytes	NULL
5	NULL
-I	NULL
4	NULL
-I	NULL
2	NULL
'	NULL
o	NULL
3	NULL
&	NULL
E	NULL
2	NULL
-I	NULL
1	NULL
0	NULL
Cir	NULL
PMs1	NULL
80H5UN-172	NULL
CD31	NULL
CD18	NULL
-	NULL
HLA	NULL
CD15	NULL
yet	NULL
boiling	NULL
the	NULL
primary	NULL
MoAb	NULL
completely	NULL
abolished	NULL
anti-body-induced	NULL
TNF-a	NULL
release	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
LPS	NULL
activation	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
require	NULL
monocyte	NULL
expression	NULL
of	NULL
CD14	NULL
,	NULL
a	NULL
glycosyl	NULL
phosphatidylinositol-linked	NULL
protein	NULL
.	NULL

The	NULL
nearly	NULL
complete	NULL
removal	NULL
of	NULL
CD14	NULL
by	NULL
treatment	NULL
with	NULL
PIPLC-specific	NULL
phospholipase	NULL
C	NULL
(	NULL
15	NULL
pg/mL	NULL
)	NULL
did	NULL
not	NULL
abrogate	NULL
the	NULL
TNF-a	NULL
release	NULL
induced	NULL
by	NULL
CD15	NULL
cross-linking	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
,	NULL
while	NULL
it	NULL
completely	NULL
abolished	NULL
TNF-	NULL
«	NULL
release	NULL
induced	NULL
by	NULL
LPS	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
monocyte	NULL
activation	NULL
mediated	NULL
by	NULL
CD15	NULL
could	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
LPS	NULL
contamination	NULL
and	NULL
suggest	NULL
a	NULL
distinct	NULL
signaling	NULL
pathway	NULL
.	NULL

Molecular	NULL
Basis	NULL
of	NULL
Cytokine	NULL
Release	NULL
Induced	NULL
by	NULL
Cross-Linking	NULL
CD15	NULL
Induction	NULL
of	NULL
cytokine	NULL
mRNA	NULL
.	NULL

-	NULL
Cross-linking	NULL
CD15	NULL
on	NULL
monocytic	NULL
cells	NULL
(	NULL
MM6	NULL
)	NULL
induced	NULL
an	NULL
increase	NULL
in	NULL
steady-state	NULL
/v	NULL
Cx	NULL
CDis	NULL
3	NULL
b	NULL
“	NULL
¥	NULL
8	NULL
4	NULL
a	NULL
Z	NULL
E	NULL
2	NULL
¥	NULL
/	NULL
Cx	NULL
Lactosamine	NULL
0	NULL
®	NULL
®	NULL
Ctr	NULL
I	NULL
T	NULL
T	NULL
1	NULL
0	NULL
2	NULL
4	NULL
6	NULL
Time	NULL
(	NULL
hour	NULL
)	NULL
Fig	NULL
3	NULL
.	NULL

Kinetics	NULL
of	NULL
CD15-mediated	NULL
TNF-	NULL
«	NULL
release	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
purified	NULL
as	NULL
in	NULL
Fig	NULL
1	NULL
and	NULL
incubated	NULL
with	NULL
primary	NULL
anti-CD15	NULL
IgM	NULL
PM81	NULL
(	NULL
10	NULL
g/mL	NULL
)	NULL
,	NULL
anti-lacto-samine	NULL
IgM	NULL
IB2	NULL
(	NULL
10	NULL
mg/mL	NULL
)	NULL
or	NULL
no	NULL
MoAb	NULL
.	NULL

Following	NULL
addition	NULL
of	NULL
a	NULL
cross-linking	NULL
secondary	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
;	NULL
goat	NULL
anti-mouse	NULL
IgM	NULL
,	NULL
culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
at	NULL
various	NULL
timed	NULL
points	NULL
from	NULL
2	NULL
to	NULL
6	NULL
hours	NULL
.	NULL

TNF-a	NULL
levels	NULL
in	NULL
the	NULL
supernatant	NULL
were	NULL
then	NULL
determined	NULL
by	NULL
ELISA	NULL
after	NULL
centrifugation	NULL
to	NULL
remove	NULL
cellular	NULL
debris	NULL
.	NULL

One	NULL
of	NULL
three	NULL
representative	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
is	NULL
shown	NULL
.	NULL

Each	NULL
point	NULL
represents	NULL
mean	NULL
TNF-a	NULL
released	NULL
.	NULL

Standard	NULL
deviations	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
were	NULL
10	NULL
%	NULL
or	NULL
less	NULL
of	NULL
the	NULL
means	NULL
.	NULL

Ctr	NULL
LO	NULL
ET	NULL
AL	NULL
Mononuclear	NULL
leukocytes	NULL
Fig	NULL
2	NULL
.	NULL

-	NULL
Cross-linking	NULL
CD15	NULL
induced	NULL
TNF-a	NULL
release	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
leukocytes	NULL
prepared	NULL
by	NULL
ficoll	NULL
gradient	NULL
centrifugation	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
three	NULL
anti-CD15	NULL
IgM	NULL
MoAbs	NULL
(	NULL
PM81	NULL
,	NULL
80H5	NULL
,	NULL
UN-172	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
ug/ml	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
cross-linked	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
goat	NULL
anti-ligM	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
;	NULL
and	NULL
allowed	NULL
to	NULL
incubate	NULL
for	NULL
6	NULL
hours	NULL
at	NULL
37°C	NULL
.	NULL

TNF-a	NULL
released	NULL
into	NULL
the	NULL
culture	NULL
supernatant	NULL
was	NULL
then	NULL
determined	NULL
by	NULL
ELISA	NULL
.	NULL

A	NULL
representative	NULL
of	NULL
six	NULL
separate	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

Cross-linking	NULL
mononuclear	NULL
leukocytes	NULL
with	NULL
anti-CD31	NULL
(	NULL
MoAb	NULL
hec-7	NULL
)	NULL
,	NULL
anti-CD11/	NULL
CD18	NULL
(	NULL
MoAb	NULL
1B4	NULL
)	NULL
,	NULL
or	NULL
anti-HLA	NULL
(	NULL
MoAb	NULL
W6/32	NULL
)	NULL
for	NULL
6	NULL
hours	NULL
was	NULL
used	NULL
for	NULL
comparison	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
cell	NULL
source	NULL
of	NULL
TNF-a	NULL
,	NULL
monocyte-depleted	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
>	NULL
95	NULL
%	NULL
lymphocytes	NULL
)	NULL
were	NULL
shown	NULL
not	NULL
to	NULL
screte	NULL
TNF	NULL
,	NULL
either	NULL
under	NULL
basal	NULL
condi-	NULL
PM81	NULL
tions	NULL
(	NULL
labeled	NULL
control	NULL
)	NULL
or	NULL
after	NULL
CD15	NULL
cross-linked	NULL
for	NULL
ﬂﬁm	NULL
6	NULL
hours	NULL
at	NULL
37°C	NULL
(	NULL
last	NULL
column	NULL
)	NULL
.	NULL

*=	NULL
Significantly	NULL
differ-CD15	NULL
ent	NULL
from	NULL
control	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
.	NULL

mRNA	NULL
levels	NULL
of	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
}	NULL
at	NULL
4	NULL
hours	NULL
as	NULL
compared	NULL
with	NULL
basal	NULL
levels	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

We	NULL
detected	NULL
a	NULL
time-dependent	NULL
increase	NULL
in	NULL
both	NULL
TNF-a	NULL
and	NULL
IL-1/	NULL
#	NULL
mRNAs	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

A	NULL
control	NULL
transcript	NULL
,	NULL
-actin	NULL
,	NULL
did	NULL
not	NULL
change	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
CD15	NULL
may	NULL
alter	NULL
mRNA	NULL
degradation	NULL
,	NULL
we	NULL
treated	NULL
MM6	NULL
cells	NULL
with	NULL
actinomycin	NULL
D	NULL
(	NULL
5	NULL
pg/mL	NULL
)	NULL
,	NULL
which	NULL
inhibits	NULL
transcription	NULL
.	NULL

While	NULL
LPS	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
enhanced	NULL
the	NULL
degradation	NULL
of	NULL
transcripts	NULL
,	NULL
CD15	NULL
cross-linking	NULL
resulted	NULL
in	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
IL-1	NULL
#	NULL
mRNA	NULL
degradation	NULL
(	NULL
Fig	NULL
7	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
CD15	NULL
may	NULL
mediate	NULL
the	NULL
changes	NULL
in	NULL
cytokine	NULL
mRNAs	NULL
,	NULL
we	NULL
also	NULL
studied	NULL
expression	NULL
of	NULL
an	NULL
promoter/enhancer	NULL
plasmid	NULL
construct	NULL
transfected	NULL
into	NULL
MM6	NULL
cells	NULL
.	NULL

We	NULL
found	NULL
that	NULL
cross-linking	NULL
CD15	NULL
on	NULL
MM6	NULL
cells	NULL
tran-siently	NULL
transfected	NULL
with	NULL
a	NULL
region	NULL
of	NULL
the	NULL
IL-1/3	NULL
promoter	NULL
span	NULL
TNF	NULL
(	NULL
ng/ml	NULL
)	NULL
o	NULL
e	NULL
es	NULL
1°	NULL
mAb	NULL
_	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
+	NULL
2°	NULL
mAb	NULL
-	NULL
-	NULL
+	NULL
+	NULL
a	NULL
a	NULL
(	NULL
Boiled	NULL
)	NULL
(	NULL
PPLC	NULL
)	NULL
Fig	NULL
4	NULL
.	NULL

LPS	NULL
was	NULL
not	NULL
involved	NULL
in	NULL
CD15-mediated	NULL
TNF-	NULL
«	NULL
release	NULL
.	NULL

Human	NULL
peripheral	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
and	NULL
CD15	NULL
was	NULL
cross-linked	NULL
as	NULL
in	NULL
Fig	NULL
1	NULL
.	NULL

Incubation	NULL
of	NULL
either	NULL
primary	NULL
MoAb	NULL
PMS1	NULL
alone	NULL
or	NULL
secondary	NULL
antibody	NULL
alone	NULL
did	NULL
not	NULL
increase	NULL
TNF-a	NULL
release	NULL
.	NULL

Also	NULL
,	NULL
boiling	NULL
the	NULL
primary	NULL
MoAb	NULL
(	NULL
100°C	NULL
for	NULL
15	NULL
minutes	NULL
)	NULL
abrogated	NULL
the	NULL
TNF-a-inducing	NULL
effect	NULL
.	NULL

Incubating	NULL
mononuclear	NULL
cells	NULL
with	NULL
phosphoinositol	NULL
specific	NULL
phospholipase	NULL
C	NULL
(	NULL
PIPLC	NULL
,	NULL
15	NULL
g/mL	NULL
)	NULL
for	NULL
60	NULL
minutes	NULL
at	NULL
37°C	NULL
,	NULL
to	NULL
remove	NULL
the	NULL
LPS	NULL
receptor	NULL
(	NULL
ie	NULL
,	NULL
CD14	NULL
)	NULL
before	NULL
cross-linking	NULL
with	NULL
CD15	NULL
MoAb	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

*	NULL
=	NULL
Significantly	NULL
different	NULL
from	NULL
control	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CD15	NULL
MEDIATES	NULL
MONOCYTE	NULL
ACTIVATION	NULL
Control	NULL
Cx	NULL
CD15	NULL
A	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
-617	NULL
bp	NULL
[	NULL
mimic	NULL
]	NULL
-444	NULL
bp	NULL
[	NULL
TNFQ	NULL
]	NULL
Control	NULL
CxCD15	NULL
B	NULL
1	NULL
2	NULL
s	NULL
4	NULL
50	NULL
6	NULL
T	NULL
8	NULL
o	NULL
%	NULL
``	NULL
-	NULL
802	NULL
bp	NULL
[	NULL
IL-	NULL
1g	NULL
]	NULL
~-	NULL
630bP	NULL
[	NULL
mimic	NULL
]	NULL
Fig	NULL
5	NULL
.	NULL

Steady-state	NULL
cytokine	NULL
mRNA	NULL
levels	NULL
increased	NULL
after	NULL
CD15	NULL
cross-linking	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
unstimulated	NULL
MM6	NULL
cells	NULL
(	NULL
as	NULL
a	NULL
control	NULL
)	NULL
or	NULL
MM6	NULL
that	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD15	NULL
cross-linking	NULL
(	NULL
PM81	NULL
,	NULL
10	NULL
g/mL	NULL
,	NULL
4	NULL
hours	NULL
)	NULL
were	NULL
used	NULL
as	NULL
templates	NULL
for	NULL
cDNA	NULL
synthesis	NULL
.	NULL

Aliquots	NULL
were	NULL
then	NULL
amplified	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10-fold	NULL
serial	NULL
dilutions	NULL
of	NULL
the	NULL
TNF-a	NULL
competitors	NULL
(	NULL
617	NULL
bp	NULL
)	NULL
or	NULL
IL-1§	NULL
competitors	NULL
(	NULL
802	NULL
bp	NULL
)	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
9	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
depicts	NULL
control	NULL
PCR	NULL
whereby	NULL
the	NULL
reverse	NULL
transcription	NULL
reaction	NULL
mixture	NULL
was	NULL
omitted	NULL
.	NULL

Lanes	NULL
2	NULL
to	NULL
5	NULL
represent	NULL
the	NULL
coamplification	NULL
of	NULL
cDNA	NULL
from	NULL
unstimulated	NULL
MMG	NULL
cells	NULL
and	NULL
serial	NULL
dilutions	NULL
of	NULL
the	NULL
competitor	NULL
DNA	NULL
at	NULL
10~	NULL
``	NULL
,	NULL
10	NULL
``	NULL
,	NULL
10-	NULL
``	NULL
,	NULL
10~*	NULL
mol/L	NULL
for	NULL
TNF-a	NULL
(	NULL
A	NULL
)	NULL
and	NULL
(	NULL
B	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Lanes	NULL
6	NULL
to	NULL
9	NULL
represent	NULL
the	NULL
coamplification	NULL
of	NULL
cDNA	NULL
from	NULL
CD15-cross-linked	NULL
(	NULL
4	NULL
hours	NULL
)	NULL
and	NULL
competitor	NULL
serial	NULL
dilutions	NULL
of	NULL
10	NULL
``	NULL
,	NULL
10-	NULL
'	NULL
``	NULL
,	NULL
10	NULL
``	NULL
,	NULL
10~*	NULL
``	NULL
mol/	NULL
L	NULL
for	NULL
TNF-a	NULL
(	NULL
A	NULL
)	NULL
and	NULL
IL-18	NULL
(	NULL
B	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
final	NULL
PCR	NULL
products	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
1.6	NULL
%	NULL
EtBr-agarose	NULL
gel	NULL
.	NULL

ning	NULL
-3757	NULL
bp	NULL
to	NULL
+15	NULL
bp	NULL
coupled	NULL
to	NULL
CAT	NULL
induced	NULL
an	NULL
=	NULL
fourfold	NULL
to	NULL
sevenfold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
over	NULL
that	NULL
of	NULL
untreated	NULL
cells	NULL
(	NULL
n	NULL
=	NULL
5	NULL
experiments	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
cytokine	NULL
release	NULL
induced	NULL
by	NULL
cross-linking	NULL
CD15	NULL
was	NULL
the	NULL
result	NULL
of	NULL
both	NULL
a	NULL
specific	NULL
increase	NULL
in	NULL
gene	NULL
transcription	NULL
,	NULL
and	NULL
in	NULL
the	NULL
case	NULL
of	NULL
IL-1/3	NULL
,	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
mRNA	NULL
degradation	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
transcription	NULL
factors	NULL
after	NULL
CD15	NULL
cross-linking	NULL
.	NULL

-	NULL
To	NULL
identify	NULL
potential	NULL
transcriptional	NULL
factors	NULL
involved	NULL
in	NULL
mediating	NULL
CD15-induced	NULL
gene	NULL
regulation	NULL
,	NULL
we	NULL
assessed	NULL
nuclear	NULL
fractions	NULL
of	NULL
stimulated	NULL
monocytes	NULL
using	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

Nuclear	NULL
extracts	NULL
obtained	NULL
from	NULL
untreated	NULL
MM6	NULL
cells	NULL
contained	NULL
minor	NULL
constitutive	NULL
levels	NULL
of	NULL
proteins	NULL
that	NULL
bound	NULL
synthetic	NULL
DNA	NULL
oligomers	NULL
representing	NULL
binding	NULL
sites	NULL
for	NULL
AP-1	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
or	NULL
SP-1	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
complex	NULL
formation	NULL
was	NULL
demonstrated	NULL
by	NULL
competition	NULL
experiments	NULL
with	NULL
unlabeled	NULL
oligonucleotides	NULL
.	NULL

Cross-linking	NULL
CD15	NULL
induced	NULL
increased	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
labeled	NULL
AP-1	NULL
oligomer	NULL
,	NULL
but	NULL
only	NULL
minimal	NULL
changes	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
no	NULL
changes	NULL
of	NULL
SP-1	NULL
levels	NULL
(	NULL
Fig	NULL
8	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cross-linking	NULL
nonfucosylated	NULL
lactosamine	NULL
carbohydrate	NULL
antigens	NULL
(	NULL
MoAb	NULL
IB2	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
,	NULL
demonstrating	NULL
specificity	NULL
.	NULL

DISCUSSION	NULL
Data	NULL
from	NULL
our	NULL
laboratory	NULL
and	NULL
others**	NULL
suggest	NULL
that	NULL
E-selectin	NULL
tethering	NULL
of	NULL
monocytes	NULL
on	NULL
cytokine-activated	NULL
endothelial	NULL
cells	NULL
may	NULL
contribute	NULL
to	NULL
monocyte	NULL
activation	NULL
during	NULL
311	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
the	NULL
inflammatory	NULL
response	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
report	NULL
that	NULL
immunologic	NULL
cross-linking	NULL
of	NULL
an	NULL
E-selectin	NULL
ligand	NULL
,	NULL
CD15	NULL
,	NULL
induced	NULL
expression	NULL
of	NULL
proinflammatory	NULL
cyto-kines	NULL
through	NULL
activation	NULL
of	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
pathways	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
CD15	NULL
cross-linking	NULL
was	NULL
spe-cific	NULL
,	NULL
as	NULL
cross-linking	NULL
of	NULL
other	NULL
surface	NULL
antigens	NULL
with	NULL
isotypic	NULL
MoAbs	NULL
to	NULL
other	NULL
carbohydrate	NULL
and	NULL
glycoprotein	NULL
antigens	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
experimental	NULL
result	NULL
can	NULL
not	NULL
be	NULL
A	NULL
10	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
_bp_	NULL
-617	NULL
[	NULL
mimic	NULL
]	NULL
-444	NULL
LTNF	NULL
]	NULL
-802	NULL
[	NULL
IL-1	NULL
]	NULL
-630	NULL
(	NULL
mimic	NULL
]	NULL
-8381	NULL
(	NULL
-	NULL
actin	NULL
]	NULL
-619	NULL
rmimicl	NULL
f-Actin	NULL
Increased	NULL
Steady-state	NULL
mRNA	NULL
(	NULL
fold	NULL
)	NULL
&	NULL
}	NULL
I	NULL
to	NULL
fl	NULL
(	NULL
+	NULL
M	NULL
+-	NULL
]	NULL
-3	NULL
r	NULL
2	NULL
iE	NULL
+3	NULL
I	NULL
ma	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Time	NULL
(	NULL
hour	NULL
)	NULL
Fig	NULL
6	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
CD15-induced	NULL
increase	NULL
in	NULL
cytokine	NULL
mRNA	NULL
levels	NULL
.	NULL

RNA	NULL
from	NULL
control	NULL
MM6	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
or	NULL
MM6	NULL
cells	NULL
cross-linked	NULL
for	NULL
various	NULL
times	NULL
(	NULL
1	NULL
to	NULL
4	NULL
hours	NULL
)	NULL
was	NULL
analyzed	NULL
as	NULL
in	NULL
Fig	NULL
4	NULL
.	NULL

For	NULL
each	NULL
experiment	NULL
,	NULL
control	NULL
tubes	NULL
in	NULL
which	NULL
reverse	NULL
transcriptase	NULL
or	NULL
RNA	NULL
was	NULL
excluded	NULL
gave	NULL
no	NULL
signal	NULL
after	NULL
amplification	NULL
,	NULL
documenting	NULL
the	NULL
absence	NULL
of	NULL
contamination	NULL
.	NULL

The	NULL
competitor	NULL
concentrations	NULL
used	NULL
were	NULL
10~*	NULL
``	NULL
mol/L	NULL
for	NULL
TNF-a	NULL
,	NULL
10~*°mol/L	NULL
for	NULL
IL-18	NULL
,	NULL
and	NULL
10°	NULL
mol/L	NULL
B-actin	NULL
.	NULL

Thirty	NULL
cycles	NULL
of	NULL
PCR	NULL
were	NULL
performed	NULL
and	NULL
the	NULL
PCR	NULL
amplified	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
.	NULL

B-Actin	NULL
served	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Increased	NULL
steady-state	NULL
mRNAs	NULL
were	NULL
calculated	NULL
using	NULL
zero	NULL
time	NULL
as	NULL
a	NULL
reference	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
representative	NULL
experiment	NULL
of	NULL
four	NULL
separate	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

312	NULL
accounted	NULL
for	NULL
by	NULL
LPS	NULL
contamination	NULL
because	NULL
boiling	NULL
of	NULL
anti-CD15	NULL
MoAb	NULL
abolished	NULL
TNF	NULL
induction	NULL
,	NULL
while	NULL
enzymatic	NULL
removal	NULL
of	NULL
the	NULL
LPS	NULL
receptor	NULL
,	NULL
CD14	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

While	NULL
the	NULL
sialylated	NULL
form	NULL
of	NULL
CD15	NULL
is	NULL
probably	NULL
the	NULL
major	NULL
recognition	NULL
motif	NULL
for	NULL
E-selectin-mediated	NULL
leukocyte	NULL
attachment	NULL
to	NULL
activated	NULL
endothelial	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
the	NULL
role	NULL
of	NULL
nonsialylated	NULL
CD15	NULL
in	NULL
monocyte	NULL
adhesion	NULL
is	NULL
less	NULL
clear	NULL
.	NULL

Our	NULL
data	NULL
,	NULL
however	NULL
,	NULL
clearly	NULL
demonstrate	NULL
that	NULL
cross-linking	NULL
CD15	NULL
,	NULL
but	NULL
not	NULL
sCD15	NULL
or	NULL
dimeric	NULL
sCD15	NULL
,	NULL
resulted	NULL
in	NULL
monocyte	NULL
activation	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
E-selectin	NULL
interaction	NULL
with	NULL
sialyl-CD15	NULL
may	NULL
predominately	NULL
mediate	NULL
initial	NULL
monocyte	NULL
teth-ering	NULL
,	NULL
while	NULL
concomitant	NULL
or	NULL
subsequent	NULL
engagement	NULL
of	NULL
the	NULL
nonsialylated	NULL
form	NULL
then	NULL
mediates	NULL
cell	NULL
activation	NULL
.	NULL

The	NULL
capacity	NULL
of	NULL
CD15	NULL
to	NULL
activate	NULL
monocytes	NULL
may	NULL
be	NULL
particularly	NULL
relevant	NULL
to	NULL
atherosclerosis	NULL
where	NULL
monocyte	NULL
adhesion	NULL
is	NULL
an	NULL
early	NULL
and	NULL
prominent	NULL
histological	NULL
feature	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
hypothesis	NULL
is	NULL
the	NULL
finding	NULL
by	NULL
Landers	NULL
et	NULL
al	NULL
``	NULL
``	NULL
that	NULL
a	NULL
subpopulation	NULL
of	NULL
adherent	NULL
macrophages	NULL
associated	NULL
with	NULL
the	NULL
intimal	NULL
lumen	NULL
during	NULL
early	NULL
lesions	NULL
of	NULL
atherosclerosis	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
tissue	NULL
factor	NULL
.	NULL

The	NULL
exact	NULL
nature	NULL
of	NULL
the	NULL
putative	NULL
protein	NULL
molecule	NULL
(	NULL
s	NULL
)	NULL
bearing	NULL
CD15	NULL
that	NULL
mediates	NULL
cell-activation	NULL
is	NULL
unknown	NULL
.	NULL
``	NULL

Albrechtsen	NULL
et	NULL
al	NULL
'	NULL
``	NULL
have	NULL
shown	NULL
that	NULL
CD15	NULL
is	NULL
associated	NULL
with	NULL
CD11/CD18	NULL
integrins	NULL
,	NULL
but	NULL
CD15	NULL
is	NULL
also	NULL
found	NULL
on	NULL
neutrophils	NULL
from	NULL
leukocyte-deficient	NULL
patients	NULL
(	NULL
lacking	NULL
CD11/CD18	NULL
)	NULL
,	NULL
``	NULL
and	NULL
blockade	NULL
of	NULL
CD11/CD18	NULL
did	NULL
not	NULL
effect	NULL
monocyte	NULL
activation	NULL
by	NULL
adhesion	NULL
to	NULL
TNF-treated	NULL
endothelial	NULL
cells	NULL
.	NULL
``	NULL

Enzy-	NULL
100	NULL
==	NULL
|	NULL
-A-	NULL
Cx	NULL
CD15	NULL
-B-	NULL
Ctr	NULL
-	NULL
#	NULL
-	NULL
LPS	NULL
é	NULL
90	NULL
-	NULL
~	NULL
&	NULL
E	NULL
&	NULL
-	NULL
~-T	NULL
B0	NULL
O	NULL
3	NULL
C	NULL
.S	NULL
E	NULL
1-	NULL
~g	NULL
x	NULL
G	NULL
E	NULL
6	NULL
g	NULL
60	NULL
O	NULL
&	NULL
\l	NULL
50	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
after	NULL
Actinomycin	NULL
D	NULL
Fig	NULL
7	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
CD15	NULL
cross-linking	NULL
on	NULL
IL-18	NULL
mRNA	NULL
stability	NULL
.	NULL

CD15	NULL
cross-linking	NULL
reduced	NULL
degradation	NULL
.	NULL

Mono	NULL
Mac	NULL
6	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°/	NULL
condition	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
anti-CD15	NULL
MoAb	NULL
(	NULL
PM81	NULL
,	NULL
10	NULL
g/	NULL
mL	NULL
)	NULL
for	NULL
20	NULL
minutes	NULL
followed	NULL
by	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
;	NULL
goat	NULL
antimouse	NULL
IgM	NULL
(	NULL
10	NULL
g/	NULL
mL	NULL
)	NULL
.	NULL

Actinomycin	NULL
D	NULL
(	NULL
5	NULL
pg/mL	NULL
)	NULL
was	NULL
added	NULL
to	NULL
cells	NULL
2	NULL
hours	NULL
after	NULL
the	NULL
CD15	NULL
cross-linking	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
at	NULL
the	NULL
designated	NULL
time	NULL
(	NULL
hours	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
steady-state	NULL
of	NULL
IL-18	NULL
mRNA	NULL
was	NULL
estimated	NULL
by	NULL
quantitative	NULL
RT-PCR	NULL
.	NULL

The	NULL
percent	NULL
of	NULL
maximal-induced	NULL
IL-18	NULL
was	NULL
calculated	NULL
using	NULL
the	NULL
2-hour	NULL
time	NULL
point	NULL
as	NULL
the	NULL
zero	NULL
time	NULL
reference	NULL
for	NULL
comparison	NULL
with	NULL
the	NULL
residual	NULL
IL-18	NULL
mRNA	NULL
at	NULL
the	NULL
later	NULL
time	NULL
points	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
representative	NULL
experiment	NULL
of	NULL
two	NULL
separate	NULL
studies	NULL
.	NULL

LO	NULL
ET	NULL
AL	NULL
CD15	NULL
Time	NULL
imin	NULL
]	NULL
0	NULL
15	NULL
15	NULL
30	NULL
60	NULL
120	NULL
180	NULL
NF	NULL
«	NULL
<	NULL
B-	NULL
Wo	NULL
mw	NULL
Wo	NULL
wo	NULL
w-	NULL
HH	NULL
wo	NULL
WH	NULL
p	NULL
®	NULL
wou	NULL
AP-1-	NULL
WW	NULL
|	NULL
imal	NULL
t	NULL
bruh	NULL
bor	NULL
tou	NULL
tah	NULL
tth	NULL
SP-A-	NULL
ow	NULL
a	NULL
”	NULL
0000	NULL
”	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Fig	NULL
8	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
transcription	NULL
factors	NULL
after	NULL
CD15	NULL
cross-linking	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
cross-linked	NULL
with	NULL
an	NULL
anti-15	NULL
MoAb	NULL
(	NULL
PM81	NULL
,	NULL
10	NULL
g/mL	NULL
)	NULL
for	NULL
varying	NULL
time	NULL
periods	NULL
were	NULL
incubated	NULL
with	NULL
``	NULL
P-labeled	NULL
oligonucleotide	NULL
binding	NULL
sites	NULL
for	NULL
AP-1	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
or	NULL
SP-1	NULL
.	NULL

Binding	NULL
of	NULL
specific	NULL
nuclear	NULL
proteins	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
shift	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
.	NULL

Cross-linking	NULL
CD15	NULL
increased	NULL
AP-1	NULL
,	NULL
while	NULL
only	NULL
minimally	NULL
effecting	NULL
NF-B	NULL
and	NULL
SP-1	NULL
.	NULL

matic	NULL
removal	NULL
of	NULL
CD14	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
cellular	NULL
response	NULL
,	NULL
indicating	NULL
a	NULL
minimal	NULL
role	NULL
,	NULL
if	NULL
any	NULL
,	NULL
for	NULL
this	NULL
LPS	NULL
receptor	NULL
in	NULL
mediating	NULL
the	NULL
CD15	NULL
effect	NULL
.	NULL

Engagement	NULL
of	NULL
a	NULL
number	NULL
of	NULL
monocyte	NULL
antigens	NULL
,	NULL
including	NULL
CD44	NULL
and	NULL
CD45	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
cause	NULL
monocyte	NULL
activation	NULL
and	NULL
lead	NULL
to	NULL
TNF-	NULL
«	NULL
@	NULL
release	NULL
in	NULL
vitro	NULL
,	NULL
``	NULL
whether	NULL
the	NULL
CD44	NULL
and	NULL
CD45	NULL
glycoproteins	NULL
bear	NULL
CD15	NULL
is	NULL
unknown	NULL
.	NULL

It	NULL
is	NULL
also	NULL
not	NULL
known	NULL
whether	NULL
a	NULL
human	NULL
homologue	NULL
of	NULL
the	NULL
recently	NULL
identified	NULL
murine	NULL
ESL-1	NULL
glycoprotein	NULL
is	NULL
present	NULL
on	NULL
monocytes	NULL
,	NULL
or	NULL
whether	NULL
ESL-1	NULL
is	NULL
capable	NULL
of	NULL
transmitting	NULL
cellular	NULL
signals	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CD15	NULL
MEDIATES	NULL
MONOCYTE	NULL
ACTIVATION	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
demonstrated	NULL
that	NULL
CD15	NULL
cross-linking	NULL
was	NULL
associated	NULL
with	NULL
specific	NULL
nuclear	NULL
signaling	NULL
events	NULL
.	NULL

Cross-linking	NULL
CD15	NULL
led	NULL
to	NULL
a	NULL
time-dependent	NULL
increase	NULL
in	NULL
nuclear	NULL
translocation	NULL
of	NULL
AP-1	NULL
and	NULL
a	NULL
small	NULL
increase	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
but	NULL
not	NULL
SP-1	NULL
.	NULL

The	NULL
AP-1	NULL
increase	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
experimental	NULL
data	NULL
from	NULL
many	NULL
laboratories	NULL
showing	NULL
that	NULL
AP-1	NULL
may	NULL
be	NULL
critical	NULL
in	NULL
monocyte	NULL
activation	NULL
including	NULL
cytokine-dependent	NULL
TNF-	NULL
«	NULL
,	NULL
tissue	NULL
factor	NULL
,	NULL
and	NULL
induc-tion	NULL
.	NULL
``	NULL

''	NULL
Sequence	NULL
analysis	NULL
of	NULL
TNF-a	NULL
,	NULL
tissue	NULL
factor	NULL
and	NULL
promoters	NULL
indicate	NULL
the	NULL
presence	NULL
of	NULL
multiple	NULL
sites	NULL
for	NULL
AP-1	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
SP-1	NULL
.	NULL

>	NULL
*	NULL
It	NULL
is	NULL
of	NULL
interest	NULL
to	NULL
note	NULL
that	NULL
LPS-depen-dent	NULL
activation	NULL
differed	NULL
from	NULL
CD15	NULL
cross-linking	NULL
in	NULL
that	NULL
LPS	NULL
increases	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
,	NULL
while	NULL
CD15	NULL
was	NULL
mainly	NULL
dependent	NULL
on	NULL
AP-1	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
signals	NULL
associated	NULL
with	NULL
CD15	NULL
ligation	NULL
are	NULL
unique	NULL
.	NULL

In	NULL
parallel	NULL
with	NULL
our	NULL
data	NULL
are	NULL
those	NULL
of	NULL
Haskill	NULL
et	NULL
al	NULL
``	NULL
``	NULL
who	NULL
have	NULL
shown	NULL
that	NULL
monocyte	NULL
adhesion	NULL
to	NULL
substratum	NULL
increased	NULL
the	NULL
mRNA	NULL
of	NULL
the	NULL
protein	NULL
components	NULL
of	NULL
AP-1	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
c-fos	NULL
.	NULL

While	NULL
the	NULL
exact	NULL
cellular	NULL
signaling	NULL
pathway	NULL
mediated	NULL
by	NULL
the	NULL
CD15	NULL
in	NULL
monocytes	NULL
awaits	NULL
further	NULL
investigations	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
CD15-mediated	NULL
monocyte	NULL
activation	NULL
may	NULL
represent	NULL
a	NULL
novel	NULL
and	NULL
distinct	NULL
signaling	NULL
pathway	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
express	NULL
our	NULL
thanks	NULL
to	NULL
Dr	NULL
John	NULL
Ho	NULL
for	NULL
his	NULL
help	NULL
in	NULL
the	NULL
study	NULL
;	NULL
Agathi	NULL
Vallianatos	NULL
,	NULL
Lisa	NULL
Bovis	NULL
,	NULL
and	NULL
Susan	NULL
Liu	NULL
for	NULL
their	NULL
excellent	NULL
technical	NULL
assistance	NULL
;	NULL
and	NULL
Zheng	NULL
Qinghu	NULL
for	NULL
graphical	NULL
illustrations	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Fan	NULL
S-T	NULL
,	NULL
Edgington	NULL
TS	NULL
:	NULL
Integrin	NULL
regulation	NULL
of	NULL
leukocyte	NULL
inflammatory	NULL
functions	NULL
:	NULL
CD11b/CD18	NULL
enhancement	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
responses	NULL
of	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
150:2972	NULL
,	NULL
1993	NULL
2	NULL
.	NULL

Lo	NULL
SK	NULL
,	NULL
Cheung	NULL
A	NULL
,	NULL
Zheng	NULL
Q	NULL
,	NULL
Silverstein	NULL
RL	NULL
:	NULL
Induction	NULL
of	NULL
tissue	NULL
factor	NULL
on	NULL
monocytes	NULL
by	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
154:4768	NULL
,	NULL
1995	NULL
3	NULL
.	NULL

Huh	NULL
HY	NULL
,	NULL
Lo	NULL
SK	NULL
,	NULL
Yesner	NULL
LM	NULL
,	NULL
Silverstein	NULL
RL	NULL
:	NULL
CD36	NULL
induction	NULL
on	NULL
human	NULL
monocytes	NULL
upon	NULL
adhesion	NULL
to	NULL
TNF-activated	NULL
endothelial	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270	NULL
:	NULL
6267	NULL
,	NULL
1995	NULL
4	NULL
.	NULL

Weyrich	NULL
AS	NULL
,	NULL
McIntyre	NULL
TM	NULL
,	NULL
McEver	NULL
RP	NULL
,	NULL
Prescott	NULL
SM	NULL
,	NULL
Zimmerman	NULL
GA	NULL
:	NULL
Monocyte	NULL
tethering	NULL
by	NULL
P-selectin	NULL
regulates	NULL
monocyte	NULL
chemotactic	NULL
protein-1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-alpha	NULL
secretion	NULL
.	NULL

Signal	NULL
integration	NULL
and	NULL
NF-kappa	NULL
B	NULL
translocation	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
95:2297	NULL
,	NULL
1995	NULL
5	NULL
.	NULL

Bevilacqua	NULL
MP	NULL
,	NULL
Nelson	NULL
RM	NULL
:	NULL
Selectins	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
91:379	NULL
,	NULL
1993	NULL
6	NULL
.	NULL

Kerr	NULL
MA	NULL
,	NULL
Stocks	NULL
SC	NULL
:	NULL
The	NULL
role	NULL
of	NULL
CD15-	NULL
(	NULL
Le*	NULL
)	NULL
-related	NULL
carbohydrates	NULL
in	NULL
neutrophil	NULL
adhesion	NULL
.	NULL

Histochem	NULL
J	NULL
24:811	NULL
,	NULL
1992	NULL
7	NULL
.	NULL

Walz	NULL
G	NULL
,	NULL
Aruffo	NULL
A	NULL
,	NULL
Kolanus	NULL
W	NULL
,	NULL
Bevilacqua	NULL
M	NULL
,	NULL
Seed	NULL
B	NULL
:	NULL
Recognition	NULL
of	NULL
ELAM-1	NULL
of	NULL
the	NULL
sialyl-Le*	NULL
determinant	NULL
on	NULL
myeloid	NULL
and	NULL
tumor	NULL
cells	NULL
.	NULL

Science	NULL
250:1132	NULL
,	NULL
1990	NULL
8	NULL
.	NULL

Polley	NULL
MJ	NULL
,	NULL
Phillips	NULL
MJ	NULL
,	NULL
Wayner	NULL
E	NULL
,	NULL
Nudelman	NULL
E	NULL
,	NULL
Singhal	NULL
AK	NULL
,	NULL
Hakormori	NULL
SI	NULL
,	NULL
Paulson	NULL
JC	NULL
:	NULL
CD62	NULL
and	NULL
endothelial	NULL
cell-leukocyte	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
ELAM-1	NULL
)	NULL
recognize	NULL
the	NULL
same	NULL
carbohydrate	NULL
ligand	NULL
,	NULL
sialyl-Lewis	NULL
X.	NULL
Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:6224	NULL
,	NULL
1991	NULL
9	NULL
.	NULL

Nelson	NULL
RM	NULL
,	NULL
Dolich	NULL
S	NULL
,	NULL
Aruffo	NULL
A	NULL
,	NULL
Cecconi	NULL
O	NULL
,	NULL
Bevilacqua	NULL
MP	NULL
:	NULL
Higher	NULL
affinity	NULL
oligosaccharide	NULL
lignads	NULL
for	NULL
E-selectin	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
91:1157	NULL
,	NULL
1993	NULL
10	NULL
.	NULL

Albrechtsen	NULL
M	NULL
,	NULL
Kerr	NULL
MA	NULL
:	NULL
Characterization	NULL
of	NULL
human	NULL
neutrophil	NULL
glycoproteins	NULL
expressing	NULL
the	NULL
CD15	NULL
differentiation	NULL
antigen	NULL
(	NULL
3-fucosyl-N-acetyllactosamine	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
72:312	NULL
,	NULL
1989	NULL
11	NULL
.	NULL

Sanders	NULL
DSA	NULL
,	NULL
Kerr	NULL
MA	NULL
,	NULL
Hopwood	NULL
D	NULL
,	NULL
Coghill	NULL
G	NULL
,	NULL
Milne	NULL
GA	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
3-fucosyl	NULL
N-acetyllactosamine	NULL
(	NULL
CD15	NULL
)	NULL
antigen	NULL
in	NULL
313	NULL
normal	NULL
,	NULL
metaplastic	NULL
,	NULL
dysplastic	NULL
,	NULL
and	NULL
neoplastic	NULL
squamous	NULL
epithelia	NULL
.	NULL

J	NULL
Pathol	NULL
154:255	NULL
,	NULL
1988	NULL
12	NULL
.	NULL

Taaties	NULL
DJ	NULL
,	NULL
Mount	NULL
SL	NULL
,	NULL
Trainer	NULL
TD	NULL
,	NULL
Tindle	NULL
BH	NULL
:	NULL
Localization	NULL
of	NULL
anti-Leu-M1	NULL
(	NULL
CD15	NULL
)	NULL
binding	NULL
sites	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
by	NULL
immu-noelectron	NULL
microscopic	NULL
examination	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Pathol	NULL
101:140	NULL
,	NULL
1994	NULL
13	NULL
.	NULL

Skubitz	NULL
KM	NULL
,	NULL
Snook	NULL
RW	NULL
II	NULL
:	NULL
Monoclonal	NULL
antibodies	NULL
that	NULL
recognize	NULL
lacto-fucopentaose	NULL
III	NULL
(	NULL
CD15	NULL
)	NULL
with	NULL
the	NULL
adhesion-promoting	NULL
glycoprotein	NULL
family	NULL
(	NULL
LFA-1/HMAC-1/GP	NULL
150,95	NULL
)	NULL
and	NULL
CR1	NULL
on	NULL
human	NULL
neutrophils	NULL
.	NULL

J	NULL
Immunol	NULL
139:1631	NULL
,	NULL
1987	NULL
14	NULL
.	NULL

Harlan	NULL
JM	NULL
,	NULL
Killen	NULL
PD	NULL
,	NULL
Senecal	NULL
FM	NULL
,	NULL
Schwartz	NULL
BR	NULL
,	NULL
Yee	NULL
EK	NULL
,	NULL
Taylor	NULL
RF	NULL
,	NULL
Beatty	NULL
PG	NULL
,	NULL
Price	NULL
TH	NULL
,	NULL
Ochs	NULL
HD	NULL
:	NULL
The	NULL
role	NULL
of	NULL
neutrophil	NULL
membrane	NULL
glycoprotein	NULL
GP-150	NULL
in	NULL
neutrophil	NULL
adherence	NULL
to	NULL
endothelium	NULL
in	NULL
vitro	NULL
.	NULL

Blood	NULL
66:167	NULL
,	NULL
1985	NULL
15	NULL
.	NULL

Mahrenholz	NULL
AM	NULL
,	NULL
Yeh	NULL
CH	NULL
,	NULL
Shively	NULL
JE	NULL
,	NULL
Hefta	NULL
SA	NULL
:	NULL
Microsequence	NULL
and	NULL
mass	NULL
spectral	NULL
analysis	NULL
of	NULL
nonspecific	NULL
cross-reacting	NULL
antigen	NULL
160	NULL
,	NULL
a	NULL
CD15-positive	NULL
neutrophil	NULL
membrane	NULL
glycoprotein	NULL
.	NULL

Demonstration	NULL
of	NULL
identity	NULL
with	NULL
biliary	NULL
glycoprotein	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:13015	NULL
,	NULL
1993	NULL
16	NULL
.	NULL

Steegmaler	NULL
M	NULL
,	NULL
Levinovitz	NULL
A	NULL
,	NULL
Isenmann	NULL
S	NULL
,	NULL
Borges	NULL
E	NULL
,	NULL
Lenter	NULL
M	NULL
,	NULL
Kocher	NULL
HP	NULL
,	NULL
Kleuser	NULL
B	NULL
,	NULL
Vestweber	NULL
D	NULL
:	NULL
The	NULL
E-selectin	NULL
ligand	NULL
ESL-1	NULL
is	NULL
a	NULL
variant	NULL
of	NULL
a	NULL
receptor	NULL
for	NULL
fibroblast	NULL
growth	NULL
factor	NULL
.	NULL

Nature	NULL
373:615	NULL
,	NULL
1995	NULL
17	NULL
.	NULL

Levinovitz	NULL
A	NULL
,	NULL
Muhlhoff	NULL
J	NULL
,	NULL
Isenmann	NULL
S	NULL
,	NULL
Vestweber	NULL
D	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
glycoprotein	NULL
ligand	NULL
for	NULL
E-selectin	NULL
on	NULL
mouse	NULL
myeloid	NULL
cells	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
121:449	NULL
,	NULL
1993	NULL
18	NULL
.	NULL

Lund-Johansen	NULL
F	NULL
,	NULL
Olweus	NULL
J	NULL
,	NULL
Horejsi	NULL
V	NULL
,	NULL
Skubitz	NULL
KM	NULL
,	NULL
Thompson	NULL
S	NULL
,	NULL
Vilella	NULL
R	NULL
,	NULL
Symington	NULL
FW	NULL
:	NULL
Activation	NULL
of	NULL
human	NULL
phagocyte	NULL
through	NULL
carbohydrate	NULL
antigens	NULL
(	NULL
CD15	NULL
,	NULL
sialyl-CD15	NULL
,	NULL
CDw17	NULL
,	NULL
and	NULL
CDw65	NULL
)	NULL
.	NULL

J	NULL
Immunol	NULL
148:3221	NULL
,	NULL
1992	NULL
19	NULL
.	NULL

Forsyth	NULL
KD	NULL
,	NULL
Simpson	NULL
AC	NULL
,	NULL
Levinsky	NULL
R	NULL
:	NULL
CD15	NULL
antibodies	NULL
increase	NULL
neutrophil	NULL
adhesion	NULL
to	NULL
endothelium	NULL
by	NULL
an	NULL
LFA-1-dependent	NULL
mechanism	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
19:1331	NULL
,	NULL
1989	NULL
20	NULL
.	NULL

Lo	NULL
SK	NULL
,	NULL
Bevilacqua	NULL
MB	NULL
,	NULL
Malik	NULL
AB	NULL
:	NULL
E-selectin	NULL
ligands	NULL
mediate	NULL
tumor	NULL
necrosis	NULL
factor-induced	NULL
neutrophil	NULL
sequestration	NULL
and	NULL
pulmonary	NULL
edema	NULL
in	NULL
guinea	NULL
pig	NULL
lungs	NULL
.	NULL

Circ	NULL
Res	NULL
75:955	NULL
,	NULL
1994	NULL
21	NULL
.	NULL

Wright	NULL
SD	NULL
,	NULL
Detmers	NULL
PA	NULL
,	NULL
Jong	NULL
MTC	NULL
,	NULL
Meyer	NULL
BC	NULL
:	NULL
Interferon-gamma	NULL
depresses	NULL
binding	NULL
of	NULL
ligand	NULL
by	NULL
C3b	NULL
and	NULL
C3bi	NULL
receptors	NULL
on	NULL
cultured	NULL
human	NULL
monocytes	NULL
,	NULL
an	NULL
effect	NULL
reversed	NULL
by	NULL
fibronectin	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
163:1245	NULL
,	NULL
1986	NULL
22	NULL
.	NULL

Ziegler-Heitbrock	NULL
HW	NULL
,	NULL
Thiel	NULL
E	NULL
,	NULL
Futterer	NULL
A	NULL
,	NULL
Herzog	NULL
V	NULL
,	NULL
Wirtz	NULL
A	NULL
,	NULL
Giethmuller	NULL
G	NULL
:	NULL
Establishment	NULL
of	NULL
a	NULL
human	NULL
cell	NULL
line	NULL
(	NULL
Mono	NULL
Mac	NULL
6	NULL
)	NULL
with	NULL
characteristics	NULL
of	NULL
mature	NULL
monocytes	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
41:456	NULL
,	NULL
1988	NULL
23	NULL
.	NULL

Schlossman	NULL
SF	NULL
,	NULL
Boumsell	NULL
L	NULL
,	NULL
Gilks	NULL
W	NULL
,	NULL
Harlan	NULL
JM	NULL
,	NULL
Kishimoto	NULL
T	NULL
,	NULL
Morimoto	NULL
C	NULL
,	NULL
Ritz	NULL
J	NULL
,	NULL
Silverstein	NULL
RL	NULL
,	NULL
Springer	NULL
TA	NULL
,	NULL
Tedder	NULL
TF	NULL
,	NULL
Todd	NULL
RF	NULL
:	NULL
Leukocyte	NULL
Typing	NULL
V	NULL
:	NULL
White	NULL
Cell	NULL
Differentiation	NULL
Antigens	NULL
.	NULL

Oxford	NULL
,	NULL
England	NULL
,	NULL
Oxford	NULL
University	NULL
Press	NULL
24	NULL
.	NULL

Davis	NULL
W	NULL
,	NULL
Sage	NULL
SO	NULL
,	NULL
Allen	NULL
JM	NULL
:	NULL
Cytosolic	NULL
calcium	NULL
elevation	NULL
in	NULL
response	NULL
to	NULL
Fc	NULL
receptor	NULL
cross-linking	NULL
in	NULL
undifferentiated	NULL
and	NULL
differentiated	NULL
U937	NULL
cells	NULL
.	NULL

Cell	NULL
Calcium	NULL
16:29	NULL
,	NULL
1994	NULL
25	NULL
.	NULL

Delude	NULL
RL	NULL
,	NULL
Fenton	NULL
MJ	NULL
,	NULL
Savedra	NULL
R	NULL
,	NULL
Perera	NULL
T-Y	NULL
,	NULL
Vogel	NULL
S	NULL
,	NULL
Golenbock	NULL
DT	NULL
:	NULL
CD14-mediated	NULL
translocation	NULL
of	NULL
NF-kB	NULL
induced	NULL
by	NULL
LAPS	NULL
does	NULL
not	NULL
require	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:22252	NULL
,	NULL
1994	NULL
26	NULL
.	NULL

Myers	NULL
TW	NULL
,	NULL
Gelfand	NULL
DH	NULL
:	NULL
Reverse	NULL
transcription	NULL
and	NULL
DNA	NULL
amplification	NULL
by	NULL
a	NULL
Thermus	NULL
thermophilus	NULL
DNA	NULL
polymerase	NULL
.	NULL

Biochemistry	NULL
30:7661	NULL
,	NULL
1991	NULL
27	NULL
.	NULL

Schrieber	NULL
E	NULL
,	NULL
Matthias	NULL
P	NULL
,	NULL
Muller	NULL
MM	NULL
,	NULL
Schaffner	NULL
W	NULL
:	NULL
Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
17:6419	NULL
,	NULL
1989	NULL
28	NULL
.	NULL

Zhang	NULL
Y	NULL
,	NULL
Doerfliet	NULL
M	NULL
,	NULL
Lee	NULL
TC	NULL
,	NULL
Guillemin	NULL
B	NULL
,	NULL
Rom	NULL
WN	NULL
:	NULL
Mechanisms	NULL
of	NULL
stimulation	NULL
of	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
by	NULL
Mycobacterium	NULL
tuberculosis	NULL
components	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
91:2076	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

314	NULL
29	NULL
.	NULL

Nelson	NULL
RM	NULL
,	NULL
Dolich	NULL
S	NULL
,	NULL
Aruffo	NULL
A	NULL
,	NULL
Cecconi	NULL
0	NULL
,	NULL
Bevilacqua	NULL
MP	NULL
:	NULL
Higher	NULL
affinity	NULL
oligosaccharide	NULL
ligands	NULL
for	NULL
E-selectin	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
91:1157	NULL
,	NULL
1993	NULL
30	NULL
.	NULL

Lawrence	NULL
MB	NULL
,	NULL
Springer	NULL
TA	NULL
:	NULL
Neutrophils	NULL
roll	NULL
on	NULL
E-selectin	NULL
.	NULL

J	NULL
Immunol	NULL
151:6338	NULL
,	NULL
1993	NULL
31	NULL
.	NULL

Landers	NULL
SC	NULL
,	NULL
Gupta	NULL
M	NULL
,	NULL
Lewis	NULL
JC	NULL
:	NULL
Ultrastructural	NULL
localization	NULL
of	NULL
tissue	NULL
factor	NULL
on	NULL
monocyte-derived	NULL
macrophages	NULL
and	NULL
macrophage	NULL
foam	NULL
cells	NULL
associated	NULL
with	NULL
atherosclerotic	NULL
lesions	NULL
.	NULL

Virchows	NULL
Arch	NULL
425:49,1994	NULL
32	NULL
.	NULL

Webb	NULL
DSA	NULL
,	NULL
Shimizu	NULL
Y	NULL
,	NULL
van	NULL
Seventer	NULL
GA	NULL
,	NULL
Shaw	NULL
S	NULL
,	NULL
Gerrard	NULL
TL	NULL
:	NULL
LFA-3	NULL
,	NULL
CD44	NULL
,	NULL
CD45	NULL
:	NULL
Physiologic	NULL
triggers	NULL
of	NULL
human	NULL
monocyte	NULL
TNF	NULL
and	NULL
IL-1	NULL
release	NULL
.	NULL

Science	NULL
249:1295	NULL
,	NULL
1990	NULL
33	NULL
.	NULL

Mackman	NULL
N	NULL
,	NULL
Brand	NULL
K	NULL
,	NULL
Edgington	NULL
TS	NULL
:	NULL
Lipopolysaccharide-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
tissue	NULL
factor	NULL
gene	NULL
LO	NULL
ET	NULL
AL	NULL
in	NULL
THP-1	NULL
monocytic	NULL
cells	NULL
requires	NULL
both	NULL
activator	NULL
protein	NULL
1	NULL
and	NULL
nuclear	NULL
factor	NULL
xB	NULL
binding	NULL
sites	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
174:1517	NULL
,	NULL
1991	NULL
34	NULL
.	NULL

Hiscott	NULL
H	NULL
,	NULL
Marois	NULL
J	NULL
,	NULL
Garoufalis	NULL
J	NULL
,	NULL
D'Addario	NULL
M	NULL
,	NULL
Roulston	NULL
A	NULL
,	NULL
Kwan	NULL
I	NULL
,	NULL
Pepin	NULL
N	NULL
,	NULL
Lacoste	NULL
J	NULL
,	NULL
Nguyen	NULL
H	NULL
,	NULL
Bensi	NULL
G	NULL
,	NULL
Fenton	NULL
M	NULL
:	NULL
Characteristics	NULL
of	NULL
a	NULL
functional	NULL
NF-kB	NULL
site	NULL
in	NULL
the	NULL
human	NULL
interleukin-18	NULL
promoter	NULL
:	NULL
Evidence	NULL
for	NULL
a	NULL
positive	NULL
autoregulatory	NULL
loop	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:6231	NULL
,	NULL
1993	NULL
35	NULL
.	NULL

Collart	NULL
MA	NULL
,	NULL
Bacuerle	NULL
P	NULL
,	NULL
Vassalli	NULL
P	NULL
:	NULL
Regulation	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
transcription	NULL
in	NULL
macrophages	NULL
:	NULL
Involvement	NULL
of	NULL
four	NULL
kB-like	NULL
motifs	NULL
and	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
forms	NULL
of	NULL
NF-kB	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:1498	NULL
,	NULL
1990	NULL
36	NULL
.	NULL

Haskill	NULL
JS	NULL
,	NULL
Johnson	NULL
CE	NULL
,	NULL
Eierman	NULL
D	NULL
,	NULL
Becker	NULL
S	NULL
,	NULL
Warren	NULL
K	NULL
:	NULL
Adherence	NULL
induces	NULL
selective	NULL
mRNA	NULL
expression	NULL
of	NULL
monocyte	NULL
of	NULL
mediators	NULL
and	NULL
proto-oncogenes	NULL
.	NULL

J	NULL
Immunol	NULL
140:1690	NULL
,	NULL
1988	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blood	NULL
===	NULL
Engagement	NULL
of	NULL
the	NULL
Lewis	NULL
X	NULL
Antigen	NULL
(	NULL
CD15	NULL
)	NULL
Results	NULL
in	NULL
Monocyte	NULL
Activation	NULL
Siu	NULL
K.	NULL
Lo	NULL
,	NULL
Douglas	NULL
T.	NULL
Golenbock	NULL
,	NULL
Philip	NULL
M.	NULL
Sass	NULL
,	NULL
Azmat	NULL
Maskati	NULL
,	NULL
Hong	NULL
Xu	NULL
and	NULL
Roy	NULL
L.	NULL
Silverstein	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/89/1/307.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Phagocytes	NULL
(	NULL
969	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

